Population Council

Knowledge Commons

2014

Validating indicators of the quality of maternal health care: Final
report, Mexico
Karla Berdichevsky
Claudia Diaz
Population Council

Katharine McCarthy
Population Council

Ann K. Blanc
Population Council

Follow this and additional works at: https://knowledgecommons.popcouncil.org/departments_sbsr-rh
Part of the Demography, Population, and Ecology Commons, Family, Life Course, and Society
Commons, International Public Health Commons, Maternal and Child Health Commons, and the Women's
Health Commons

How does access to this work benefit you? Let us know!
Recommended Citation
Berdichevsky, Karla, Claudia Diaz, Katharine McCarthy, and Ann K. Blanc. 2014. "Validating indicators of
the quality of maternal health care: Final report, Mexico." Mexico City: Population Council.

This Report is brought to you for free and open access by the Population Council.

Final Report

VALIDATING INDICATORS OF THE
QUALITY OF MATERNAL HEALTH
CARE: FINAL REPORT, MEXICO

2014

Karla Berdichevsky
Claudia Diaz-Olavarrieta
Katharine McCarthy
Ann Blanc

The Population Council confronts critical health and development issues—from stopping the spread of
HIV to improving reproductive health and ensuring that young people lead full and productive lives.
Through biomedical, social science, and public health research in 50 countries, we work with our
partners to deliver solutions that lead to more effective policies, programs, and technologies that
improve lives around the world. Established in 1952 and headquartered in New York, the Council is a
nongovernmental, nonprofit organization governed by an international board of trustees.

Population Council
Insurgentes Sur #2453 Piso 9
Obregónn Benito Juárez, Mexico City
Mexico, D.F., 1090
Tel: +52 55 5999 8645
Fax: +52 55 5999 8631
popcouncil.org

Suggested citation: Berdichevsky, K., Diaz-Olavarrieta, C., McCarthy, K., and Blanc, A. 2014. “Validating
Indicators of the Quality of Maternal Health Care: Final Report, Mexico.” Mexico City: Population Council.

Table of Contents
Executive Summary ............................................................................................................................................. 3
List of Abbreviations ............................................................................................................................................ 6
Tables and Figures .............................................................................................................................................. 7
Study Background ............................................................................................................................................... 9
Study Overview .................................................................................................................................................. 11
Ethical Clearance ........................................................................................................................................... 12
Methods ............................................................................................................................................................. 13
Research Site & Study Population................................................................................................................ 13
Recruitment and Data Collection Procedures ............................................................................................. 13
Results................................................................................................................................................................ 17
Study Sample and Descriptives .................................................................................................................... 17
Indicator Validity Results ............................................................................................................................... 20
Discussion .......................................................................................................................................................... 45
Literature Cited .................................................................................................................................................. 51
Appendices

1

Annex A, Table 1

List of Assessed Indicators and Measured Coverage, Matched Data

Annex A, Table 2

Near Universal and Rare Indicators, Unmatched Data

Annex A, Table 3

Indicators with High ‘Don’t Know’ Responses, Unmatched Data

Annex B, Table 1

Indicator Validation Results, Matched Data

Acknowledgments
We would like to thank and acknowledge all those who contributed to this project and who are
dedicated to improving the measurement of the quality of maternal health care. We particularly thank
Saumya RamaRao and Charlotte Warren who were co-investigators on the project. These individuals
provided leadership, technical support, and insights throughout the project. We acknowledge Hannah
Taboada who conducted a comprehensive literature review of indicators to be assessed in the study
and developed the initial tools used in the study. We also acknowledge Tahilin Karver who provided
assistance to study implementation. We appreciate the advice of the maternal health experts who
advised on the study and are grateful to the women and providers who allowed us to share their
experiences. The study was supported by the Maternal Health Task Force through a grant to the Harvard
School of Public Health from the Bill & Melinda Gates Foundation.

2

Executive Summary
Despite widespread use, the majority of indicators proposed as measures of the quality of maternal
health services have not been sufficiently validated. To help accurately track progress towards national
and global maternal health goals, the present study sought to validate and identify a set of maternal
health indicators that can be practically applied in facility and population-based surveys. To evaluate the
indicators, the study employed a facility-based design. The study was conducted in public /government
hospital facilities in Kenya and Mexico. Participants included women aged 15-49 who underwent labor
and delivery at participating study facilities and the providers who attended them. Women’s self-report
of obstetric and immediate postnatal maternal and newborn care received was compared against a
“gold standard” of observations by a trained third party observer during labor and delivery.
This report presents results of the Mexico study. Data collection took place between November 2013
and April 2014. A total of 600 births were observed and the mothers participated in an exit interview
prior to hospital discharge. A large proportion of assessed indicators were either routinely practiced or
rarely occurred. The lack of variation in observed interventions limited the ability to conduct full validity
analysis for some indicators. Of the 108 indicators assessed, 48 had sufficient variation for validity
analysis using area under the receiver operator characteristic curve (AUC) and inflation factor (IF)
analysis.
Of assessed indicators, 5 met both acceptability criteria for both AUC (AUC>0.6) and IF (0.75<IF<1.25).
These were: whether a urine sample was taken upon hospital admission, whether an injection or IV
medication was received at some time during labor (before the birth of the baby), episiotomy,
hemorrhage, and receipt of blood products. Findings suggest events that caused pain, concern or were
considered ‘important information’ by mothers, were particularly salient for women and may have
enhanced recall. Important to note is that although a urine screening test, hemorrhage and receipt of
blood products each met both validity criteria, these indicators had moderate or low sensitivity (50% or
lower). As the lower sensitivity and specificity for these indicators balances out at the aggregate level,
these indicators may be more appropriately applied to estimate the population-based coverage of these
events. Also of note is that while an indicator of whether an injection of IV medication was received at
some time during labor met both validity criteria, additional findings indicate that women are unable to
report on the indication for the medication (if received for induction or augmentation of labor). Taken
together, these indicators are recommended dependent on the objective of their use (i.e., for accurately
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classifying ‘true positive’ and ‘negative’ cases or for obtaining an approximate population-based
prevalence).
A total 28 indicators met acceptability criteria for one of the validity measures; 19 indicators met the IF
criteria and 9 met the AUC criteria only. While having high sensitivity and specificity for indicators is
important in ascertaining which women received care at an individual level, approximating the broader
population-based prevalence can also provide actionable data on the coverage of maternal and
newborn health care received. For example, in some cases, underreporting of true cases and false
positive reporting of negative cases (i.e., low indicator sensitivity and specificity) equaled out to
generate acceptable estimates for monitoring coverage at the population level. We recommend caution
with regard to low-prevalence indicators that, without near-perfect specificity (i.e., true negative
classification), are likely to be overestimated.
Of key objective of the present study was to validate the skilled birth attendance indicator. Attendance
by a skilled provider (defined as any doctor- specialized or a general practitioner, medical resident or
nurse) was near universal and unable to be robustly analyzed. Cross-tabulation results, however,
indicate that the majority of women observed to have skilled birth attendance, correctly reported
receiving skilled care (high sensitivity). We also assessed if women could accurately ascertain what
category of provider was responsible for the majority of care. We found a combined doctor (any type)
and medical resident indicator could be reported with accuracy at the population-level, but was not
suitable for individual-level classification given the tendency for overreporting by women. Given the little
distinction between skilled doctor categories however, the inability of women to distinguish between
finer distinctions of providers may be less programmatically meaningful than the ability to report on the
coverage of the indicator at the aggregate level.
Although it was not possible to validate indicators with near universal practice, descriptive crosstabulation results suggest that women may be able to report on some aspects of routine care with
accuracy. For example, women reported on their newborn’s birthweight with near perfect classification,
although so few women incorrectly reported their newborn birthweight that robust analysis was not
possible. An additional indicator of potential high use not able to be assessed in the present study was
the type of facility where women delivered. Although the present study was not designed to evaluate
this indicator, descriptive results suggest a high proportion (85%) of women correctly identified the type
of institution where they delivered. Results also suggest that the two-part question methodology to
identify institution type, also used in DHS and MICS surveys, is important. These indicators should be
explored further in studies with multiple facility types (private and public sector), or different practices
for recording newborn weight.
4

In sum, study findings suggest women in a facility-based setting validly report 5 indicators of maternal
health services and immediate newborn care. An additional 19 indicators met the IF criteria only and 9
met AUC criteria only. We recommend the use of these indicators with caution and dependent on
whether the purpose is to identify coverage at the population level, or to distinguish among true positive
and negative cases at an individual level. Results suggest indicators related to timing, technical
terminology, and the sequence of events may be reported with difficulty. Taken together, findings
suggest the validity of a number of indicators may be highly dependent on context and question
wording. Future studies should explore how key terms and questions related to timing and order of
events are understood by women in order to enhance indicator accuracy.
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Study Background
Global monitoring of the percentage of women who have received quality maternal health services is
crucial to guide the scale-up and allocation of resources to reduce preventable maternal deaths. Given
difficulties in measuring maternal deaths, the proportion of births attended by skilled health personnel
and the proportion of births delivered in health facilities have become widely used indicators to
measure progress towards maternal health goals. Coverage rates of ‘skilled attendance’ and
‘institutional deliveries’ have become benchmarks for quality of maternal health care routinely tracked
by national and international agencies.
Reliance on these indicators requires the assumption that women delivering in an institution with the
assistance of a skilled attendant will also have access to essential services, such as emergency
obstetric care and lifesaving commodities including uterotonics, magnesium sulfate, and antibiotics.1,2
Given discrepancies in the quality of care between providers and facilities, however, identifying the
actual interventions that a woman receives is necessary to provide a more accurate assessment of the
coverage of key interventions.
Little previous research has been conducted on this topic. To our knowledge, the two most widely used
proxy indicators – skilled attendance at birth and institutional delivery – have not been empirically
validated or systematically evaluated. In addition, there have been few attempts to test the feasibility of
collecting data on specific elements of the care received by women during labor and delivery.3-7
In response to a call to increase reliable maternal health information in the Lancet “Manifesto for
Maternal Health”, a 2013 PLOS Medicine special issue reported in partnership with the Child Health
Epidemiology Reference Group (CHERG), includes three quantitative studies in this area. These studies
examine the validity of women’s reports of: 1) the indications for cesarean sections in Ghana and the
Dominican Republic8, 2) indicators of care received by women and their newborns during labor, delivery,
and the postnatal period in Mozambique,9 and (3) indicators of care received by women and newborns
in rural China.10 In these studies, women’s reporting of events during labor and delivery is compared
against a reference standard, either medical records or observation in a health facility. In addition, a few
small qualitative studies have examined whether specific events during labor and delivery (e.g., cord
cutting) were understood and recalled by women, whether women were able to recall their sequence
and timing, and the terms used to describe them.11-13
9

The present study extends previous research by comparing women’s self-reports of maternal and
newborn service provision during the intrapartum and early postnatal periods prior to discharge from a
hospital facility to third party observation at the time of delivery. The study also provides insight into
factors (e.g., participant variables, type of delivery, instances of complications or other events) that may
influence the accuracy of recall. The results of the study inform the recommendation of a select number
of indicators that have the potential for valid and reliable measurement and for integration into routine
population-based and facility-based data collection systems.
Mexico and Kenya were chosen as study sites in light of variations in the status of maternal health and
the coverage and organization of maternal health services. This report presents results from the Mexico
study.
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Study Overview
OBJECTIVE
The goal of the study is to improve monitoring of the quality of maternal health care through identifying,
developing, and validating maternal health indicators that can be practically applied in populationbased surveys. The main question addressed by this research is: Can accurate information on the
quality and content of maternal health care received by women during labor and delivery be selfreported by women in a survey format? The two specific objectives of the study are:
1. To assess the validity of women’s reports of skilled birth attendance; and
2. To assess the validity of women’s reports of indicators of the quality of routine obstetric and
immediate postnatal service delivery.

INDICATOR SELECTION
To identify quality care indicators for maternal health to be validated, a landscaping scan was
conducted from April to July 2012. The scan focused on indicators currently in use or proposed for use,
including both population-based and facility-based indicators. Indicators were identified by performing a
key word search of electronic databases, including: PUBMED, POPLINE, JSTOR and EMBASE. We
conducted additional searches of publications from organizations known for their involvement in
measuring maternal health care, such as WHO, UNICEF, UNFPA, MCHIP, AMDD and IMMPACT, and by
searching reference lists of identified papers and reports. Key search terms included maternal health,
safe motherhood, quality of care, indicator, valid, skilled attendant, neonatal, perinatal, obstetric, and
intrapartum. No studies were excluded on the basis of language or date of publication.
An indicator matrix was developed to organize findings. From an identified 2,505 documents, 71
provided information on indicators for assessing quality in maternal healthcare. This listing was used to
select indicators for validity testing (see Annex A, Table 1). These indicators were considered the most
commonly used or critical variables for assessing the quality and coverage of maternal care. The
observation and interview questionnaires were translated into the appropriate local dialects and
underwent minor modifications to improve local understanding and clarity for participants.
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STUDY DESIGN
To accomplish the stated objectives, the validation study employs a facility-based design with
comparisons against a gold standard. Specifically, women’s reports on indicators of the quality of
maternal health care they received are compared against third party observations of the care provided
at the time of labor and delivery using a structured checklist.
Third party observations were chosen as the reference standard since they are likely to reflect all facets
of the care-giving process. In the event that additional information or clarification was needed, medical
and facility records were also checked. Women’s self-reports of the services they received at the time of
labor and delivery were gathered via exit interviews prior to their discharge from the participating
hospital facility, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City, Mexico.

ETHICAL CLEARANCE
The protocol was approved by the Population Council’s Institutional Review Board in May 2013 (IRB
Protocol 594) and by the Ethics and Research Committees of the Hospital General de México “Dr.
Eduardo Liceaga” in October 2013. No participants were enrolled in the study until ethical approval was
obtained from both ethics committees.
Ethics and Research Committees Research Division
Hospital General de México “Dr. Eduardo Liceaga”
Dr. Balmis 148
Colonia Doctores
Mexico City, 06726
Mexico
Tel. +52 55 2789200 ext. 1164
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Methods
RESEARCH SITE & STUDY POPULATION
Study Population:
The study population consisted of women whose births were documented by study data collectors at the
participating study facility between November 2013 and April 2014. Women aged 15-49 who were
admitted for labor at the study facility and who consented to study participation were eligible for
inclusion. The study population also included the providers who attended participating women in labor
and delivery and whose labor and delivery care was observed by study data collectors.
Study Location: Hospital General de México Dr. Eduardo Liceaga (HGM), Mexico City
All women were recruited from the above hospital, a public facility in Mexico City. HGM provides
comprehensive obstetric care to women with normal pregnancies who are self-referred for admission, in
combination with high-risk pregnancies that are referred from other public primary or secondary health
care institutions. The hospital population in Mexico City tends to have a lower-than-average
socioeconomic status and characteristically lacks health insurance. Patients may travel large distances
to HGM. Slightly more than half of the patients who receive health care at HGM live in Mexico City, with
a significant proportion from the neighboring State of Mexico (37%) and 5% from the rest of the
country.14
On average in Mexico, hospital-based deliveries are proportionately high. Data from the most recent
national health survey indicate that 94% of women delivered with a medical doctor.15 HGM is one of the
public hospitals in Mexico City with the highest volume of obstetric patients and in 2013 provided
delivery care for 4169 women, of which 2235 (54%) were vaginal births.

RECRUITMENT PROCEDURES
Data Collectors
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Two types of data collectors were involved in this study: observers, who registered the quality and
content of obstetric care provision; and interviewers, who applied questionnaires to women prior to
hospital discharge. Observers were general medical practitioners or nurses with sufficient clinical
training to accurately observe delivery room practices and procedures and to know how to conduct
themselves professionally. Interviewers were social workers and psychologists with qualitative research
experience. We recruited only female interviewers in order to facilitate rapport with participating women.
All data collectors were external to HGM and not personally known to hospital staff in order to minimize
observer bias and to ensure respondents’ anonymity. In addition, we selected a study coordinator from
the pool of observer applicants. The study coordinator had previous research and managerial
experience and provided supervision and support to fieldwork teams.
Job openings for data collectors were posted on university websites and list serves. Interested
applicants who fulfilled our criteria were interviewed and asked for professional references. Most of our
observers held part-time jobs elsewhere or were studying for admission into medical residency
programs. Their shifts were thus scheduled around their availability to give them flexibility to continue
with those activities.

Data Collector Training
Data collection training for observers and interviewers took place over two consecutive days in October
2013. Training included detailed study protocol description, practice using data collection instruments,
and key ethical aspects of research, stressing the importance of informed consent. Sessions included
teaching tools such as role-playing dynamics and question-and-answer sessions to clarify technical
concepts. All field staff were required to complete and submit a certificate of the NIH online training
course “Protecting Human Research Participants” (https://phrp.nihtraining.com/users/login.php) to
ensure that they fully understood and adhered to human subject research ethics. Training manuals
were developed and distributed to all data collectors, who were instructed to use them as a reference
during study implementation.
Study interviewers were trained to listen and observe intently, without displaying judgmental attitudes
towards information they received. They were instructed to read out questions as worded in the
questionnaires and to offer additional explanations only when strictly necessary. Observers received
training on procedures for being unobtrusive and for locating themselves toward the head of the client
rather than the foot when possible. Observers also received information on how to conduct themselves
in the event that they witnessed unacceptable provider behavior that put clients at risk of morbidity and
14

how and when to intervene. Both interviewers and observers were instructed to keep all data collection
instruments in strict confidentiality.
Because all but two of our observers and our study coordinator took new jobs or began their medical
residencies in January 2014, we conducted new recruitment and training to replace these staff. The
second training was a one-day workshop that covered the same content as the original training.
Contrary to what occurred with the observers, the interviewer group remained throughout the study
period. Although no refresher trainings were conducted as a group, our study coordinators gave
constant feedback to observers and interviewers and were available to respond to their questions and
solve problems as they arose.

Process for Participant Recruitment and Informed Consent
All women who were undergoing labor and delivery at HGM and met the inclusion criteria were eligible
for study participation. Inclusion criteria were: 1) women aged 15-49 years old (the same age range as
in the DHS), 2) admitted for delivery at HGM and able to provide consent, and 3) the health care
providers who attended the woman in labor and delivery. Women were excluded if they were unable to
provide consent (including unconsciousness or presenting with a complication) or if their stage of labor
was considered too advanced by the attending medical personnel. Women were eliminated from the
study if a cesarean section was indicated at any point during labor.
When women were admitted to the labor ward, health providers asked them whether they were willing
to meet with a member of the research team. If the woman gave her permission to speak with an
observer, the health provider identified an appropriate time (relative to her clinical status) to meet with
her. The observer then explained the study procedures, including the fact that a researcher would stand
in the corner of the room during her labor and delivery and use a checklist to record the actions of the
doctors or nurses.
Written informed consent was then obtained from interested participants and, in accordance with local
ethical guidelines, consent was also requested from their spouses/common law partner or parents
when applicable. For participants who were minors, information about the study was also provided to,
and written consent sought from, their parent or spouse/ common law partner (as responsible parties).
Everyone who participated in the informed consent process was given a copy of the consent form with
the study information and signature page. The main informed consent process included both study
15

activities: observation and exit interview. Before each data collection activity, study interviewers
confirmed that women still wished to participate and requested their verbal consent.
Provider consent was obtained to observe health care workers in the labor and delivery ward. Before
study implementation began, several meetings were organized by the OB-GYN director for our research
team to explain the study to nurses and doctors, answer their questions, and obtain their informed
consent. Once the study began, the study coordinator and observer team individually approached
providers who had not attended the larger staff meetings to obtain their consent. This was especially
important since new hospital personnel were constantly recruited.
A list of providers who gave their consent was available for observers to check against before their
observations. Consultations were observed only if provider consent had been obtained. Very few
providers did not agree to participate in the study and, in those cases, we did not conduct observations
of the services they provided.

Data Collection Procedures
Data collection was carried out from 1 November 2013 to 23 April 2014. Data were collected
continuously, seven days per week, 24 hours per day. There were 3 shifts for staff carrying out
observations, with two data collectors per shift. On average, observers worked 3 to 4 shifts per week,
while interviewers worked individually and were assigned an average of two shifts per week. Interviewer
shifts (10 am to 5 pm) were designed to cover the period when patients were discharged from the
hospital. Data collection was briefly interrupted at the beginning of February, as our first group of
observers left the study and we trained a new team. Data collection was also suspended during national
holidays.
With the objective of gaining better insight into data quality, we conducted debriefing sessions with the
fieldwork teams two weeks after concluding data collection. We carried out two separate group
interviews: one per observer and interviewer teams. The information collected was used to interpret our
quantitative findings.
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Results

Figure 1. Participant response rates (vaginal
delivery), Mexico.
Hospital General de Mexico

STUDY SAMPLE

Consented to study
participation (vaginal delivery
only)
N = 616

A total of 779 women admitted for labor at Hospital
General were recruited to participate. Because of
hospital policies that allowed the complete observation
only of women who underwent vaginal deliveries, data

Successfully observed
during labor & delivery.
N = 609; Observation
Rate: 98.8%

Could not be located
or left the hospital.
N = 7; Loss to FU
Rate: 1.2%

collection for women who became indicated for
cesarean sections was discontinued at the time of
indication. Figure 1 depicts a flow chart of data

Completed exit
interview.
N = 600; Follow-up
Rate: 98.5%

Lost to follow-up or
refused survey.
N = 9; Loss to FU
Rate: 1.5%

collection for women who could be observed throughout
their labor and delivery (i.e., women who delivered by

600 women with matched
data.

vaginal birth). Specifically, 616 women who consented
to participate in the study delivered by vaginal birth. Of these women, 609 (99%) were successfully
observed during labor and delivery. A total of 7 (1%) women were not observed as a result of being sent
home because they did not progress into labor, because they could not be located after recruitment, or
because they requested to be discharged from the hospital prior to delivery. Of the women whose labor
and delivery was observed, 600 completed an exit interview prior to hospital discharge. Exit interviews
were not completed for 9 women (2%) who either refused participation at the time of interview or
because they received an early hospital release. 600 observer reports and client exit interviews were
accurately matched and could be analyzed. In the following sections, all data refer to women who
delivered by vaginal birth only, unless otherwise specified.

SAMPLE DESCRIPTIVES
Descriptive statistics on the sample’s socio-demographic and delivery characteristics are presented in
Table 1. The mean age of women was 24 years (Std. Dev. ±6) and ranged between 15 and 42 years.
The majority of women (56%) were living with a partner (en unión libre) or were currently married (18%),
whereas one-quarter were single and had never been married (26%). Approximately half of women had
given birth previously (52%). Of women who had previously delivered, most of the women had one prior
birth. The highest parity among women was seven prior births. Nearly all of the women reported
secondary school education or higher as their highest level of completed education (92%). Of these
women, approximately 40% had completed or obtained at least some post-secondary education (42%)
17

or tertiary/ preparatory school (41%), and less than 10% had completed or obtained at least some
education at the university or graduate level (8%). Of observed vaginal deliveries, 3% were assisted with
forceps.
Study participants who became indicated for cesarean operation after study enrollment (and for which
observation was discontinued at the time of indication) did not differ from all other women on key
sociodemographic characteristics such as age, marital status, or education level. Women who
underwent a cesarean operation had, on average, fewer previous births than women who delivered
vaginally (mean difference: 0.3± Margin of Error 0.1, p<0.001).

Maternal and Newborn Outcomes
A total of 604 deliveries were observed, including 2
sets of twins. Less than 1% of births resulted in a
stillbirth (n=2) or neonatal death (n=1) (i.e., newborn
died within the first hour of delivery).
The majority of participants reported coming to the
facility because they had planned to deliver there
(72%), while 28% reported coming because they had
a problem, such as needing to be referred to an
alternate facility for medical care or an inability to pay.

TABLE 1. Sample background characteristics*.
Age

Percentage (%)

15-19

27.2

20-24

36.3

25-29

19.2

30-34

9.7

35-39

5.9

40+

1.6

Prior parity ( total # live births)
0

47.7

1

29.4

2

14.7

3

5.6

4 or more

2.6

Educational level

Complications were observed among 14% of women.

None

Most complications were observed following delivery

Primary

8.4

Secondary

42.3

Higher

49.2

(44%), while approximately 40% occurred during
delivery (38%), and 19% occurred prior to delivery.
The most common type of complication was
hemorrhage (APH+PPH) (8% of women), followed by
eclampsia (2%), and prolonged labor (>12 hours), (2%
of women). Less than 1% of women with
complications experienced more than one.

0.2

Marital status
Single, never married

25.5

Married

17.8

Living together

55.7

Separated

1.0

Widowed

0.0

Type of vaginal delivery
Unassisted

97.5

Assisted forceps

2.5

Note: *Data refer only to women who delivered vaginally.

Service Delivery Coverage
The indicators selected for validity testing are presented in Annex A, Table 1. The table describes the
matched prevalence of each indicator by women’s self-report (‘reported’ prevalence) and observer
18

report (‘true’ prevalence), excluding “Don’t Know” responses. The observed prevalence of indicators
ranged from extremely rare (<5%) to near universal (>95%). The broad range indicates that some
preventive interventions were almost always implemented, while other harmful practices rarely
occurred. Indicators meeting these criteria are listed in Annex A, Table 2.
A total of 18 indicators had an observed prevalence >95%, while 13 indicators had an observed
prevalence <5%. Universal or rare practices reflected standard hospital practices or policies. For
example, it was the standard practice for newborns to be wrapped in a towel and then placed with the
mother, rather than being placed directly naked against the mother’s chest (skin-to-skin) and then
covered with a towel or cloth. Other standard practices were that women were generally not allowed to
eat or drink during labor or to have a support companion present during labor or delivery.
Of note is that few HIV tests were offered (2%). This was in part because few HIV tests were available at
the facility, and because the practice of first checking the woman’s HIV status by either asking the
woman or consulting her records was high (70%) (n=169). Similarly, few women were observed to
receive HIV testing (1%). A greater proportion of women who were offered HIV testing were observed to
receive the test (3 of 10 women; 30%). Provider hand-washing practices were also notably low. In
contrast to the low level of observed hand-washing, there was a near universal practice of providers
wearing high-level disinfected or sterile gloves during examinations of the woman.

For all indicators, women and observers were given the option to respond, “Don’t Know”. The proportion
of women who responded “Don’t Know” to indicators was minimal (<5%). Indicators where the
proportion of women who responded “Don’t Know” exceeded 5% are reported in Annex A, Table 3.
The greatest proportion of women responded “Don’t’ Know” to the indicator, “Did anyone give you a
medication called ‘oxytocin’ to make your womb contract or become firm?” (37% “Don’t Know”).
Potential explanations for this high percentage are that women were not informed if they were given
oxytocin or that women did not know what the drug was for and its name was not salient. Other
practices with a high self-reported “Don’t Know” prevalence were also related to indicators of care
received in the immediate postnatal period. This included the oxytocin indicator, as well as whether a
uterotonic for the prevention of postpartum hemorrhage (PPH) was received following delivery– whether
in the first few minutes after delivery, “anyone [gave] medication intravenously through a tube in your
arm” (7% “Don’t Know”). At the same time, observer reports indicate that nearly all women received the
prophylactic uterotonic oxytocin following delivery, and that it was administered via an IV line in the arm.
Taken together, these descriptive findings suggest that many women have difficulty reporting on
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indicators related to receiving a uterotonic for the prevention of postpartum hemorrhage. High “Don’t
Know” responses were also given for other postnatal practices related to immediate newborn care and
postnatal health checks.
The percentage of women who were able to report on whether anyone offered them an HIV test was
also notably low (23% “Don’t Know”). Study data collectors noted that many women did not know what
HIV was, or confused it with human papillomavirus (HPV), which may account for the high “Don’t Know”
percentage. Indicators on whether the provider washed his or her hands before examining her or
whether the newborn was given anything to drink besides breastmilk in the first hour after delivery may
reflect uncertainty due to the practice occurring outside of the woman’s view.
Observer responses of “Don’t Know” were also minimal across indicators and, where they occurred,
were generally less than 2% of responses (Annex A, Table 3). Six indicators had an observer report of
“Don’t Know” of 3% or greater. These indicators generally related to practices that may have occurred
outside of the labor and delivery room, such as whether the baby was given anything other than
breastmilk to eat within the first hour after birth (6% “Don’t Know”), whether the provider checked the
woman’s HIV status, or whether the provider washed his or her hands before examining the woman (4%
and 3% “Don’t Know”).

VALIDITY OF QUALITY OF CARE INDICATORS

Analytic Approach
The general approach for the validity analysis relied on comparing women’s self-report of each quality of
care indicator to its “true” classification according to the observer report (i.e., reference standard) at the
time of facility-based delivery. Using these data, sensitivity and specificity for each indicator were
calculated using two-by-two tables. An indicator’s sensitivity is the proportion of actual positives (women
who received care) that were correctly identified as such (i.e., “true positive rate”). An indicator’s
specificity is the proportion of negatives (women who did not receive care) that were correctly identified
as such (i.e., “true negative rate”). For indicators meeting the criteria of at least 5 counts per cell, we
also calculated the area under the receiver operating curve (AUC) and the inflation factor (IF).
Receiver operating curve analysis is a valuable method to describe the accuracy of diagnostic tools by
plotting the tradeoff between sensitivity (true positive rate) against its false positive rate (or 120

specificity). In practice, the area under the curve (AUC) represents the “average accuracy of a diagnostic
test” and summarizes the test’s sensitivity and specificity by a single number.16-18 An AUC of 1.0 can be
interpreted as a test with perfect accuracy, while an AUC of 0.5 represents a random guess.19 To assess
the population-based validity of indicators, we also estimated each indicator’s inflation factor (IF). Using
an equation by Vecchio, each indicator’s estimated sensitivity, specificity is applied to its true
prevalence (or observer report) to estimate the prevalence of an indicator that would be obtained using
a population-based survey.20 By comparing the ratio of the estimated survey-based prevalence to its
true population prevalence (observer report or ‘reference standard’), we estimate the degree to which
each indicator would be over- or under-estimated if assessed using a population-based survey.21
A priori benchmark criteria for ‘valid’ indicators were an AUC>0.6 and an IF between <1.25 and >0.75
and were informed by criteria previously used in the literature.9,10 Use of the two methods provides
complementary data to inform indicator use in population-based surveys. Indicators with sufficient
variation to allow for validity analysis are
presented in Annex B. For indicators listed in the

Box 1A. Descriptive frequencies: Type of facility.

text, prevalence data refer to matched indicator

Can you tell me the type of facility where you gave birth to your
baby? (Self’-report)

data. In the results section that follows, the AUC
and its margin of error are also reported.

Number
Public Sector

Facility Arrival & Initial Assessment
Type of facility

report on the type of facility where they delivered.
surveys, women were asked to identify where they
gave birth by first indicating whether they
delivered in a public or private sector institution.
Women were then asked to specify the facility

Govt. hospital

380

85.2

Govt. clinic/health center

7

1.6

Govt. health dispensary

0

0

Other public sector

11

2.5

Private hospital

45

10.1

Private clinic

3

0.7

Private maternity home

0

0

Private Sector

Of interest is whether women can accurately
Replicating the methodology of DHS and MICS

Other private sector
Total Reported in Categories

0

0

446

100

Box 1B: Woman not able to determine whether private or public
but specified facility details.
Number
Percent
Facility name (Hospital General de
Mexico)
120
83.3
Hospital and public/ govt. type

type as a hospital, health clinic/center, health

Hospital (other)

post, or other location. If women were unable to

Other facility detail (location, level, etc.)

determine whether the facility was public or

Percent

Total Specified

5

3.5

13

9.0

6

4.2

144

100

private, they were asked to name the facility. Since the participating study facility was a
public/government hospital (100% true or ‘observed’ prevalence), the present study was not designed
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to assess whether women can accurately report on this indicator. However, cross-tabulation results
show that of women who classified the facility as public or private sector and then specified the level of
facility, 85% of women correctly classified the type of facility as a public hospital (Boxes 1A-B).
24% of women (n=144) were not able to classify Hospital General as a private or public sector facility
but did specify the facility name or other details. 83% of these women correctly specified the facility
name as “Hospital General” or “Hospital General de México”. An additional 9% of women who could not
identify the type of facility were able to report it was a hospital of some kind (but not a public sector or
governmental hospital). Notably, 4% of women were able to report the facility was a hospital and part of
the public or government sector (e.g., by reporting “Hospital público”, “Hospital federal”, or “Hospital de
asistencia pública”). The fact that women could identify the facility as a government or public sector
hospital by being asked to report the facility name in an open-ended question but were not able to
classify the facility using pre-existing categories suggests that more women are able to accurately report
on the facility type than are captured in initial questioning. Some women (4%) also provided additional
correct details about the facility, such as its level, location, or ability to offer specialized care, but not
whether the facility was in the public sector or a hospital.

TYPE OF FACILITY: SUMMARY
Descriptive results suggest that both parts of the DHS and MICS indicator question methodology –
categorical responses and specific facility names - are important in capturing self-reported information
on the type of facility. These results should be interpreted with care as they are descriptive only.
Initial assessment practices
Box 2A: Cross-tabulation: Urine sample taken at admission.

Two indicators of the initial client assessment
phase could be assessed. Other practices were

Did someone ask you to give them a urine sample at or near your
admission to the facility?
Observer Report (Number)

meet criteria for robust analysis. Assessed

No

Yes

Total

No

361

72

433

Yes

67

72

139

Total

428

144

572

indicators in the initial client assessment phase
were: (1) whether the woman’s HIV status was
checked and (2) whether the woman’s urine

Self-report
(Number)

near universal or rarely occurred and did not

sample was taken upon admission.
Only one indicator, whether the woman’s urine sample was taken, met both study validity criteria (AUC:
0.6717± 0.04, IF: 0.97). A urine sample screen is an early test for preeclampsia/ eclampsia, or
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elevated blood pressure in the mother which can lead to deadly seizures, one of the leading causes of
maternal mortality and morbidity. Despite meeting both study validity criteria, the urine screen indicator
had moderately low sensitivity (50%), indicating that only half of women whose urine sample was taken
reported that the intervention took place (Box 2A). However, the indicator did have high specificity
(84%), indicating that a large proportion of women who did not have their urine sample taken accurately
reported that the intervention did not occur. Since urine screening test can identify a potentially lifethreatening complication, the low sensitivity of the indicator signifies it would not capture critical
information.
The indicator “HIV status checked” met only the IF validity criteria. The underreporting of true cases
(55% sensitivity) and false positives among negative cases (1-specificity, 52%), however, balances out,
so the IF approximates the population-based prevalence that would be obtained via household survey
(AUC: 0.5129± 0.04, IF: 0.78).
Initial assessment practices that we were unable to assess by robust analysis because of near universal
or rare occurrence of the intervention included: (1) provider hand washing or antiseptic use before
initial examination of the woman, (2) whether high-level disinfected or sterile gloves were worn for
vaginal examination, (3) whether the woman’s blood pressure was taken, (4) whether the woman was
offered or (5) received an HIV test, and (6) whether the fetal heart rate was checked with a
fetoscope/ultrasound (Annex A, Tables 1-2). Descriptive results for these indicators show that nearly all
women received and positively reported receiving these standard practices of care. However, of the
relatively few women who did not receive such interventions, nearly all falsely reported that these
interventions took place, resulting in low specificity rates, <10%. As a result, women overestimated
indicators of provider hand washing or antiseptic use (96% self-report prevalence compared to 2%
observed prevalence), being offered an HIV test (14% self-report prevalence; 2% observed prevalence),
and receiving an HIV test (16% self-report prevalence; 1% observed prevalence).

INITIAL ASSESSMENT: SUMMARY
1 of 2 assessed indicators of facility-based care received met study criteria for valid
measurement― whether a urine sample was taken. While this indicator had high accuracy in
accurately classifying women who did not receive the intervention, its sensitivity of 50%
suggests that nearly half of women who received the intervention were not identified. An
indicator on whether HIV status was checked met the IF criteria only.

23

Respectful Care
Five indicators reflected aspects of women-centered care (proxy for respectful care), including whether
the woman was: (1) allowed to drink liquids or eat, (2) encouraged or assisted to ambulate during labor,
(3) encouraged or assisted to assume different positions in labor, (4) allowed to have a support person/
companion present during labor and delivery, and (5) whether a support person/ companion was
actually present during labor or birth.
In general, the majority of proxy measures of respectful or woman-centered care were not observed to
take place (e.g., being able to eat or drink during labor, being allowed or having a support companion
during labor and delivery). A correspondingly low proportion of women reported that such interventions
took place, limiting the ability to conduct full analysis. Only one indicator, whether the woman was
encouraged or assisted to ambulate during labor, had sufficient numbers for robust analysis.
Specifically, being encouraged or assisted to ambulate in labor was observed to occur among 22% of
women, while it was reported by only 8%. This indicator did not meet study validity criteria (AUC:
0.4966± 0.04, IF: 0.37) and was underreported by women.

PROVIDER RESPECTFUL CARE: SUMMARY
Only 1 of 5 indicators could be assessed by robust analysis─ whether the woman was encouraged to
ambulate during labor. This indicator did not meet study validity criteria and was particularly
underreported by women.

Induction / Augmentation of Labor

Induction of labor

Box 3A. Cross-tabulation: Induction of labor by uterotonic.
2-item indicator constructed: 1) someone intervened to bring on
labor and 2) medication through IV was given to bring on labor.
(Proxy for observer report of uterotonic given).
Observer Report (Number)
Induces labor with uterotonic

Approximately 17% of all women reported

No

Yes

Total

No

440

47

487

Yes

54

18

72

Total

494

65

559

rather than their labor starting spontaneously. Of
women who reported that someone intervened
(n=91), the majority (79%) reported receiving

Self-report
(Number)

“someone did something” to bring on their labor,

medication through an IV line in their arm; while 21% reported their membranes were ruptured. We
were unable to assess the validity of receiving membrane rupture for induction of labor, since observers
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did not record the indication for receiving this intervention (i.e., whether performed for induction or
augmentation of labor).
To assess the validity of ‘received a uterotonic for labor induction’, we constructed a two-item indicator
of women who reported “something was done to bring on labor” and who subsequently reported
receiving a uterotonic (i.e., medication through an IV line, as no option for intramuscular injection was
given) to bring on labor (13%). This indicator was compared to observer reports of whether the woman
received a uterotonic to induce labor (12%) (Box 3A). This indicator did not meet the AUC validity criteria
(AUC: 0.5838± 0.04, IF: 1.11). In particular, this indicator had low sensitivity (28%), indicating that not
all women who received a uterotonic for labor induction reported receiving the intervention (Annex B).
However, the indicator did meet the IF criteria, indicating that it may be acceptable to approximate the
population-based prevalence.
We also sought to assess whether women could accurately report on the method by which a uterotonic
for labor induction was received. Robust analysis, however, was not possible since all observers
indicated that women received the uterotonic through an IV line.
Augmentation of labor
More than half (52%) of all women reported “someone did something to strengthen or speed up” their
labor. The most common method of uterotonic administration reported for augmentation of labor was
an IV line inserted in the arm (both womens’ and observers’ report).
Box 4A. Cross-tabulation: Augmentation of labor by uterotonic.

A two-item indicator in which women who reported
“something was done to speed up or strengthen
labor” and who subsequently reported receiving a

2-item indicator constructed: 1) someone intervened to
strengthen labor and 2) received medication through an injection
or IV line to speed up or strengthen labor.
(Proxy for observer report of uterotonic given).

uterotonic (i.e., an injection or medication through

Observer Report (Number)
Augments labor with uterotonic

an IV line) to strengthen labor (42%) was
receiving a uterotonic to augment labor (75%)
(Box 4A). This indicator did not meet the IF criteria
(AUC: 0.6539± 0.04, IF: 0.56). Similar to receiving

Self-report
(Number)

compared to the observer report of the woman

No

Yes

Total

No

95

179

274

Yes

22

176

198

Total

117

355

472

a uterotonic for induction of labor, this indicator
had relatively low sensitivity (50%), indicating that not all women who received a uterotonic for the
augmentation of labor reported the intervention.
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All women who received a uterotonic for labor augmentation received it by IV line, so robust analysis for
this indicator was not possible. Cross-tabulation results suggest that women are not able to accurately
report on the method of augmentation of labor. Specifically, only slightly more than half of women (57%)
who were observed to receive medication via IV line for labor augmentation reported receiving the
intervention via this route.
Injection or IV medication during labor
Box 4B. Cross-tabulation: Uterotonic for induction or augmentation
of labor (general indicator).

In addition to being asked to specify the method
by which their labor was brought on or

Before the birth of your baby, did you receive any injection or IV
medication during labor?
Observer Report (Number)
Composite indicator of whether observer reported IV or
injection for induction or augmentation of labor.

strengthened, women were asked a general
indicator on whether “before the birth of the
medication during labor?” This indicator was
used as a proxy measure for receiving a
uterotonic for the induction or augmentation of

Self-report
(Number)

baby, did you receive an injection or IV

labor (no providers administered uterotonic in

No

Yes

Total

No

78

130

208

Yes

59

304

363

Total

137

434

571

tablet form). In contrast to the observer report on receiving a uterotonic (by injection or IV line) for labor
induction or augmentation, this indicator met both study validity criteria (AUC: 0.6349± 0.04, IF: 0.84)
(Box 4B).
A comparison indicator (which was constructed
in analysis to combine women’s responses to
two survey questions) that compared women’s
self-report of whether an injection or IV

Box 4C. Cross-tabulation: Uterotonic for induction or augmentation of
labor (composite indicator).
Composite indicator of whether women reported receiving an
injection or IV medication for induction or augmentation of labor
(constructed in analysis).

medication was received for either induction or

Observer Report (Number)
Composite indicator of whether observer reported
IV or injection for induction or augmentation of
labor.

augmentation of labor did not meet either study
validity criteria (AUC: 0.6947± 0.04, IF: 0.65).
(59%), indicating that not all women who
received a uterotonic by injection or IV
medication reported receiving either
intervention for the purposes of bringing on or
strengthening labor (Box 4C).
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Self-report
(Number)

Specifically, this indicator had lower sensitivity

No

Yes

Total

No

91

148

239

Yes

23

214

237

Total

114

362

476

Taken together, these results suggest that at an individual classification level women can report
whether they received an injection or IV medication at some point during labor before delivery, but not
the indication for the medication (whether received for induction or augmentation of labor). An indicator
on whether a uterotonic was received for the induction of labor may be appropriate for measuring
population-based coverage of this practice.
Membrane rupture (induction or augmentation of labor)

27% of all women reported receiving membrane rupture (either for induction or augmentation of labor),
compared to 57% of observers reporting this intervention. Given the relatively low sensitivity of the
indicator (38%), the indicator meet only the AUC validity criteria (AUC: 0.6333± 0.05, IF: 0.47). The low
sensitivity of the indicator indicates that the majority of women who received membrane rupture did not
report it.
INDUCTION & AUGMENTATION OF LABOR: SUMMARY
Results suggest women may be able to report on whether an injection or IV medication was received at
some point during labor before delivery, but not the indication for the medication (for induction or
augmentation of labor). Women did not report accurately on whether membrane rupture was received
for the induction or augmentation of labor at the population level.

Uterotonic for Prevention of Postpartum
Hemorrhage (PPH) (Post-delivery)
Active management of the third stage of
labor (AMTSL), which includes administration

Box 5A. Cross-tabulation: Received prophylactic uterotonic (Y/N).
In the first few minutes after the delivery of your baby, did anyone give you… (1)
an injection in the thigh or buttock? (2) medication intravenously through a tube
in your arm? (3) tablets to swallow or hold in your mouth or placed in your
rectum? (Select all)
Observer Report (Number)
Uterotonic administered (Y/N)

of a uterotonic following delivery, is a critical

No

Yes

Total

No

0

232

232

Yes

4

357

361

Total

4

589

593

hemorrhage, a leading contributor to
maternal mortality and morbidity.22 Nearly all
women received a uterotonic following

Self-report
(Number)

intervention to prevent postpartum

delivery (99%), and nearly two-thirds (64%) received the medication within 3 minutes of birth. All
uterotonics were administered via IV line, most often by IV drip (93%), a bolus injected into an IV line
(6%), or an IV drip combined with intramuscular injection (<1%).
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To assess women’s ability to accurately report whether a uterotonic for the prevention of postpartum
hemorrhage was administered following delivery, women were asked, “In the first few minutes after the
delivery of your baby, did anyone give you an injection in your thigh or buttock, medication intravenously
(through a tube in your arm) or tablets to swallow, hold in your mouth, or placed tablets in your
rectum?” (option to select all applicable interventions received).
It was not possible to conduct robust analysis of this indicator, given that nearly all women received the
intervention. Cross-tabulation results (Box 5A) indicate that of women who received the intervention,
less than two-thirds reported receiving it (sensitivity: 61%). These results suggest that the composite
proxy indicator constructed to assess whether women were administered a uterotonic for PPH did not
capture a substantial proportion of women who received the intervention.
Timing of uterotonic administration for PPH
To examine whether women could
accurately report on the timing in which
the uterotonic was received, we
assessed women’s self-report of
whether any IV medication, injection in

Box 5B. Cross-tabulation: timing of prophylactic uterotonic (1-3 minutes postdelivery).
In the first few minutes after the delivery of your baby, did anyone give you… (1)
an injection in the thigh or buttock? (2) medication intravenously through a tube
in your arm? (3) tablets to swallow or hold in your mouth or placed in your
rectum?
Observer Report (Number)
Uterotonic administered 1-3 minutes following birth

the thigh or buttocks, or tablets (oral,
immediately (in the first few minutes)
following birth. This composite proxy
indicator was compared to the observer
report of whether the uterotonic was

Self-report
(Number)

vaginal or rectal) were received

No

Yes

Total

No

85

143

228

Yes

124

228

352

Total

209

371

580

administered up to 3 minutes following birth. This indicator met only the IF study validation criteria (AUC:
0.5106± 0.04, IF: 0.95). Specifically, of women who were observed to receive the prophylactic
uterotonic within this time frame, 61% reported it. The moderate sensitivity level indicates that a
considerable proportion of women did not report the intervention when it in fact took place. The
indicator was also marked by a high degree of false positive reporting (i.e., low specificity). Over half of
women (59%) who did not receive the intervention within 3 minutes of delivery falsely reported that it
took place (Box 5B). These results suggest that at an individual level, this indicator is unlikely to be
validly reported, as both underreporting of true cases and false positive reporting among negative cases
occurs. However, at a population-level, IF results indicate the low sensitivity and specificity cancel out
and the indicator produces an acceptable estimate of the population-based prevalence.
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We also examined the accuracy of women’s self-reports of whether the prophylactic uterotonic was
received following the delivery of the placenta. For this comparison, we assessed women’s report on
whether any IV medication, injection in her thigh or buttocks, or tablets (oral, vaginal or rectal) were
given in the first few minutes after the delivery of the placenta. We compared this proxy indicator to the
observer report on whether the uterotonic was received up to 3 minutes following the delivery of the
placenta. A high proportion of women (94%) reported receiving IV medication, an intramuscular
injection, or tablets following the delivery of the placenta. In contrast, only one-fifth of women (20%)
were observed to receive a prophylactic uterotonic following the delivery of the placenta. The proxy for
women’s self-report on receiving prophylactic uterotonic following the delivery of the placenta had high
sensitivity (96%), demonstrating nearly all women who received the intervention were able to report it.
However, the indicator was marked by a high false positive rate (94%) and did not meet either study
validation criteria criteria (AUC: 0.5097± 0.04, IF: 4.71).
Method of uterotonic administration
All observers reported that the prophylactic uterotonic was administered by IV line (either by IV bolus, IV
drip, or IV drip plus IM injection), compared with 61% of women. There was not sufficient variation to
assess the accuracy of women’s reporting by delivery method. However, cross-tabulation results show
that of the women who received uterotonic by IV line (any IV method) (n=498), less than two-thirds
report having received medication by this administration route (specificity: 61%).
Type of uterotonic
Box 5C. Cross-tabulation: Oxytocin received after birth.

The most common type of uterotonic
administered was oxytocin (97%), followed by

Immediately after the birth of your baby, did anyone give you
medication called oxytocin to help your womb become firm?
Observer report (Number)

ergonovine and carbetocin. Since oxytocin was
analysis was not possible. However, crosstabulation results demonstrate that of women
who received oxytocin, 50% of women

No

Self-report
(Number)

the standard medication administered, robust

Total

No

1

178

179

Yes

2

177

179

Total

3

355

358

accurately reported receiving the medication by its brand name (Box 5C).
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Yes

Since oxytocin was the uterotonic
administered to nearly all women and its route
of administration was by IV line (97%), we
compared women’s self-report of receiving a
uterotonic by administration route (assessed
by a proxy composite measure of ‘yes’ to
whether the woman received any of the

Box 5D. Cross-tabulation (Self-Report): Prophylactic uterotonic and
oxytocin.
Q1. In the first few minutes after the delivery of your baby, did anyone
give you… (1) an injection in the thigh or buttock? (2) medication
intravenously through a tube in your arm? (3) tablets to swallow or hold
in your mouth or placed in your rectum?
Q2. Immediately after the birth of your baby or sometime before the
delivery of the placenta, did anyone give you a medication called
oxytocin? (*constructed in analysis*)

following: (1) an injection in the thigh or

Self-Report (Number)
Q2.

a tube in arm, (3) or tablets given orally or
rectally in the first few minutes following birth),
and their reporting ‘yes’ to the question “after
the birth of your baby, did anyone give you a
medication called oxytocin to help your womb
become firm or contract?”.

Self-report (Number) Q1.

buttock, (2) medication intravenously through

No oxytocin

Yes
oxytocin

Total

Injection

9

21

30

IV line

52

125

177

Tablet

0

1

1

Total

61

147

208

The cross-tabulation results of women’s self-report on these two indicators are presented in Box 5D.
While only descriptive analysis was possible, these results demonstrate that 85% of women (125 out of
147) who reported receiving medication by IV line following delivery also reported receiving oxytocin. Of
note is that 85% (52 out of 61) of women who reported receiving IV medication following delivery did
not report receiving oxytocin. To determine whether these women had in fact received oxytocin
(highlighted cell, Box 5D), we conducted a cross-tabulation with the observer report. Data show that all
but one of these women (99%) received oxytocin by IV line. Therefore, 51 of the 52 women were correct
in noting they had received an IV line, but incorrect in not indicating that they had received oxytocin.
These results suggest not all women can report on receiving a uterotonic by name.

UTEROTONIC FOR THE PREVENTION OF POSTPARTUM HEMORRHAGE: SUMMARY
Nearly all women received oxytocin via IV line following delivery, meaning there was insufficient variation
to assess whether a woman can report receiving a uterotonic for the prevention of postpartum
hemorrhage, the route of administration, or the name of the drug. Cross-tabulation results, however,
suggest that a large proportion of women who received a uterotonic would not be captured using a
composite study indicator. Descriptive results also suggest that women are unlikely to be able to report
on receiving oxytocin by name. The timing in which the uterotonic was received (in the first few minutes
of birth or after the delivery of placenta) was robustly analyzed and did not meet criteria for valid
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reporting at the individual level. IF results suggest the indicator on whether a uterotonic was received
within 3 minutes after delivery could approximate the population-based prevalence.

Active management of the third stage of labor
Active management of the third stage of labor for the prevention of postpartum hemorrhage includes 3
components: (1) administration of a uterotonic for PPH, (2) controlled cord traction, and (3) uterine
massage immediately following delivery of the placenta. Robust analysis was possible only for whether
uterine massage was performed immediately following delivery of the placenta. This indicator had
moderately high sensitivity (80%) and low specificity (20%), indicating that approximately 20% of women
who received uterine massage following delivery of the placenta were not captured by the indicator and
80% of women who did not receive the intervention reported that it had taken place. Given that nearly
all women received and reported receiving prophylactic uterotonic and controlled cord traction, it was
not possible to assess these indicators using robust analysis. However, cross-tabulation results indicate
that a substantial proportion (38%) of women did not report receiving a uterotonic following delivery,
although they were observed to do so. Controlled cord traction was also a near universal practice, which
limited the ability to conduct robust analysis. Most women who received controlled cord traction
reported it (sensitivity: 94%), but of the few cases where controlled cord traction was not implemented,
there was a high degree of false reporting (95% false positive reports).
A composite indicator of the 3 essential
components of the active management of the
third stage of labor (AMTSL) was assessed.

Box 6. Cross-tabulation: All 3 components of AMTSL received.
Prophylactic uterotonic + controlled cord traction + uterine massage
following delivery of placenta received.
Observer Report (Number)

This indicator did not meet the AUC study
Cross-tabulation results in Box 6 indicate that
approximately one-quarter of women who
received all 3 components of care were not

No

Self-report
(Number)

validity criteria (AUC: 0.4986± 0.04, IF: 0.93)

Yes

Total

No

24

109

133

Yes

76

340

416

Total

100

449

549

captured by the indicator (sensitivity: 75%). Additionally, about three-quarters of women who did not
receive all 3 elements of care reported that they had (1- specificity: 76%). The AMTSL composite
indicator, however, did meet IF criteria, suggesting it may be suitable for assessing population-based
coverage of the practice.
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ACTIVE MANAGEMENT OF THE THIRD STAGE OF LABOR: SUMMARY
A composite indicator on whether 3 essential elements for active management of the third stage of
labor—uterotonic for the prevention of postpartum hemorrhage, controlled cord traction, and uterine
massage following delivery of the placenta—did not meet study validity criteria. The indicator was both
under- and overreported by women. The composite AMTSL indicator did meet the IF criteria, indicating a
close approximation of the population-based prevalence of the practice.

Skilled Birth Attendance
Skilled provider during labor and delivery
Both observers’ and women’s self-reported coverage of skilled birth attendance [defined as a general
“doctor” category, doctor subcategories (identified as an ob-gyn specialist, a medical resident or general
practitioner), or a nurse] was high for the primary birth attendant during labor and delivery and for the
provider who delivered or ‘caught’ the newborn during birth (>90%). Given the near universal
occurrence of this practice, it was not possible to conduct robust analysis. Cross-tabulation data,
however, indicate that nearly all women observed to have a skilled provider ‘catch’ their newborn at
birth correctly reported it as such (specificity: 97%). A similarly high proportion of women observed to
have a skilled birth attendant as their primary provider in labor (97%) or delivery (93%) also identified
the level of their provider as such. However, the vast majority of women not observed to receive skilled
birth attendance at each of these stages falsely reported receiving skilled attendance, indicating low
indicator specificity (>90% false positive reporting across birth phases). These results should be
interpreted with caution given the small number of women who did not receive skilled birth attendance
(n=19 in labor; 42 in delivery), since the lack of variation in the data prevented full analysis.
Main provider who assisted in delivery
Most deliveries were attended by medical residents (90%) as the primary provider, followed by medical
interns (7%), general practitioners or ob-gyns (2%), and nurses (<1%) (observed prevalence, excluding
‘Don’t Know’ responses). The vast majority of women reported a doctor as the primary provider during
their delivery (93%), without being able to define the category to which the medical provider belonged to
(i.e., ob-gyn, medical resident, and general practitioner or medical intern). Specifically, of the 542
women who reported a doctor as their main provider during delivery 40 (7%) providers were actually
medical interns (Table 2).
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TABLE 2. Cross-tabulation: Main provider during delivery.
Observer Report (Number)
Self- Report (Number)

Doctor
/Ob-gyn

Medical
resident

Medical
Intern

Nurse

Student
Nurse

Other

Total

Doctor /Ob-gyn

14

487

40

1

0

0

542

Medical resident

0

17

0

0

0

0

17

Medical intern

0

11

2

0

0

0

13

Nurse

0

11

0

1

0

0

12

Student nurse

0

0

0

0

0

0

0

Don’t Know

0

9

2

0

0

0

11

Total

14

535

44

2

0

0

595

In Mexico, there is little distinction between

Box 7. Cross-tabulation. Main provider during delivery—doctor /ob-gyn
or medical resident.

doctor categories; however, while medical

Observer report (Number)

residents are considered skilled attendants,
combined indicator of whether the main
provider during delivery belonged to any

Self-report
(Number)

medical interns are not. We assessed a

No

Yes

Total

No

3

22

25

Yes

41

510

511

Total

44

532

576

doctor subcategory of skilled provider (i.e., obgyn, medical resident, or general practitioner) (Box 7). While robust analysis was not possible, crosstabulation results show the indicator would have high sensitivity (96%). Cross-tabulation results in Table
2 suggest women may be unable to distinguish the presence of less prevalent, unskilled providers, such
as medical interns. The discrepancy in reporting may reflect differences in how the ‘main’ provider was
conceptualized by women in comparison to observers. For example, it is possible that women identified
the ‘main’ provider as the highest-ranking attendant present during delivery. Observers, instead,
identified the ‘main’ provider as the provider who spent the most time, or administered the majority of
care received by the woman. Additionally, given the low prevalence of instances when the main provider
was not a doctor/ob-gyn or medical resident, without near-perfect specificity these indicators are likely
to be overreported.
Main provider who ‘caught’ the newborn
In addition to identifying their main provider during delivery (“Who was the main provider assisting you
during delivery?”), women were asked, “Who was the main provider who actually delivered your baby
(caught the baby)?” The majority of providers who ‘caught the newborn’ following delivery were either
doctors/ob-gyns or medical residents (90% self-report compared to 91% observed prevalence). Of the
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485 women who reported that the provider who caught their newborn was a doctor, 9% were either
medical interns or nurses.
It was possible to validate a combined indicator on the category of birth attendant who ‘caught’ the
newborn during delivery as a doctor/ob-gyn or medical resident. This indicator did not meet the AUC
criteria (AUC: 0.5203± 0.04). Specifically, at an individual classification level, the combined doctor/obgyn/medical resident indicator was marked by high sensitivity (90%) and low specificity (14%). These
results indicate women had low accuracy in reporting when the main provider did not belong to one of
the skilled provider doctor subcategories (doctor or medical resident), and instead was some other less
common type of provider (e.g., nurse, student nurse, or medical intern). However, at the aggregate level
for this indicator, differences in sensitivity and specificity canceled out to produce an acceptable IF level
(IF: 0.98). The IF result of close to 1 highlights the potential of the indicator to obtain an acceptable
population-based coverage estimate of the provider category.
Main provider labor
Similar to delivery, the most prevalent providers during labor were medical residents or doctors/ob-gyn
(82% self-report and 96% observed prevalence). Of the 501 women who reported a doctor was the main
provider during labor, 12% were either medical interns, nurses, or student nurses (Table 3). The
combined indicator on whether the provider was a doctor/ob-gyn or medical resident during labor was
robustly analyzed. The indicator did not meet study AUC validity criteria (AUC: 0.5477± 0.04), with high
sensitivity (82%) and notably low specificity (27%). The indicator did meet IF criteria, suggesting the
potential for this indicator to obtain acceptable population-based estimates of coverage of a doctor/obgyn during labor (IF: 0.85) at an aggregate level.
TABLE 3. Cross-tabulation: Main provider during labor.
Self-report
(Number)
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Observer Report (Number)
Doctor/
ob-gyn

Medical
resident

Medical
Intern

Nurse

Student
Nurse

Other

Total

Doctor /ob-gyn

7

423

12

56

3

0

501

Medical resident

3

26

1

0

0

0
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Medical intern
Nurse

0
0

19
76

2
4

0
0

0
0

0
0

21
80

Student nurse

0

4

0

0

0

0

4

Don’t Know

0

10

0

0

0

0

10

Total

10

558

19

56

3

0

646

Additional providers during delivery

In addition to identifying their primary provider during labor and delivery, women were asked to list all
additional providers who were present both in labor and delivery. For delivery, the next most common
additional provider was a doctor (80% self-report), followed by a nurse (81%), medical student or intern
(26%), and medical resident (14%). Women also specified an ‘other’ option, and listed specific types of
doctors such as a pediatrician (39%) or anesthesiologist (10%) as also present. Because women and
observers were asked to report all types of providers present, rather than specifying one main provider,
there were sufficient numbers to assess the accuracy of women’s self-report of multiple categories of
providers.
Results of the validity analysis reflect the same trend as the primary provider findings, in that the
majority of additional providers noted to be present during labor were doctors/ob-gyns or medical
residents (82% self-report, 88% observed prevalence). Although the combined doctor/ob-gyn /medical
resident indicator had a similar prevalence rate reported by women and observers, it was marked by low
specificity (21%) and met only the IF validity criteria (IF: 0.93). Other indicators of additional providers
during delivery or labor that met the IF validity criteria alone were whether additional providers were a
nurse or nursing student.
Additional providers—skilled
The near universal presence of a skilled provider (doctor of any type, or nurse) as an additional provider
in both labor and delivery limited our ability to conduct robust analysis. It is noteworthy; however, that
almost all of the handful of women who were not observed to have a skilled provider as an additional
provider present during labor or delivery falsely reported the presence of one. This finding should be
interpreted with caution since there were few cases in which an additional skilled provider was not
present during labor and delivery.
Skilled birth attendant: summary
In summary, across birth phases and provider roles, the category of provider most commonly observed
to be present during labor and delivery were skilled provider doctors (i.e., ob-gyns, general practitioners,
or medical residents) either as the primary provider or as an additional provider present. Since there is
little distinction in Mexico between these doctor subcategories, including medical residents, a combined
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indicator was assessed. No composite doctor/ob-gyn /medical resident indicator met both validity
criteria. Across birth phases the combined doctor indicator had low specificity, indicating that women
were likely to report any doctor category as the main provider or as an additional provider who was
present when they were not. Results from ‘other providers’ present during labor or delivery, for which
robust analysis was possible, also reflected these findings. Given the low prevalence of other types of
providers present during labor and delivery, without near-perfect specificity these indicators are likely to
be overestimated by women at the individual level. However, across birth phases and provider roles, 8
birth attendant indicators met the IF criteria alone. They included whether the main provider who caught
the newborn during delivery was a doctor/ob-gyn or medical resident. Birth attendant indicators that
met the IF criteria alone may be useful for population-based coverage of these provider types. Given
that the fine distinction between subcategories of doctors (i.e., ob-gyn, general practitioner, or medical
resident) is likely less programmatically useful than assessing the prevalence of skilled attendance, the
composite doctor indicator may be of particular use.
Number of providers who attended birth

FIGURE 2. Scatterplot: Women’s and observers’ report
on the number of providers who attended the birth.

The number of providers who attended the woman’s
birth was observed to range from 1 to 12 (mean: 4 ±
2). Approximately half of women were attended by
more than 4 providers (45% true prevalence) during
their delivery, while 75% of women were attended
by six providers or fewer. The average number of
providers who attended the birth by women’s selfreport was higher (mean: 6 ± 3) and ranged from 2
to 22, reflecting the trend for women to overreport
the number of providers present (Figure 2).
Women’s self-reports and observers’ reports on the number of providers present were weakly correlated
(r=0.2, p<0.001). No indicators of the number of providers who attended the birth met both study
validity criteria. In general, women’s self-report of the number of providers present at their birth were
marked by high rates of false positive reporting (i.e., low specificity) (Annex B).

SKILLED BIRTH ATTENDANT: SUMMARY
In contrast to other settings, in Mexico doctors and medical residents attend the vast majority of births
in hospital settings, and both are considered skilled providers. An indicator that combined these skilled
doctor sub-categories did not meet both validity criteria, irrespective of delivery phase and provider role
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(main provider or additional provider present). Across birth phases the combined doctor indicator had
low specificity, indicating that women were likely to report any doctor category as the main provider or
as an additional provider who was present when they were not. Given the low prevalence of other types
of providers, without near-perfect specificity (i.e., true negative classification) these indicators are likely
to be overestimated by women at the individual level. However, across birth phases and provider roles,
8 birth attendant indicators did meet the IF validation criteria, including whether the main provider who
caught the newborn during delivery was a doctor/ob-gyn/medical resident. These indicators may be
useful for estimating population-based coverage of these provider types.

Immediate Newborn Care
Three indicators of immediate newborn care had sufficient variation for validity analysis: (1) whether the
baby was given to the mother immediately after birth, (2) whether the newborn was breastfed within the
first hour after birth, and (3) whether something other than breastmilk was given to the baby to eat or
drink in the first hour after birth.
None of these indicators met both study validity criteria. For all 3 indicators, women’s self-reported
prevalence exceeded the observed prevalence. While the indicator of breastfeeding in the first hour
after birth had fairly high sensitivity (81%), it was also marked by only moderate specificity (44%),
indicating that nearly 60% of women not observed to breastfeed in the first hour after birth falsely
reported that they had. The indicators of whether the baby was immediately placed with the mother
after birth and whether the baby was given something other than breastmilk to eat or drink in the first
hour after birth were marked by both moderate sensitivity and specificity (Annex B), indicating both the
underreporting of true cases and false reporting of true negative cases. The reporting discrepancies
may reflect differences in how women understood the terms ‘immediately’ or the ‘first hour’ after
delivery.
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Newborn thermal care
A high proportion of newborns were immediately dried
following delivery (94% observed prevalence). Since
nearly all mothers also reported that their newborns
were immediately dried (99%), robust analysis was

Box 8. Cross-tabulation (Self-Report): Newborn skin-to- skin
indicators.
Q1. Did someone place the baby on your chest, against your skin
immediately after delivery?
Q2. Was your baby wrapped in a towel while lying against your
chest or naked against your skin?

not possible.

other indicators of newborn thermal care, results
suggest indicator wording has important implications
for women’s reporting accuracy. Specifically, almost
no observers (<1%) reported the newborn was placed
skin-to-skin against the mother’s chest following

Q1. Self-Report (Number)

Although validity analysis was also not possible for

Q2. Self-Report (Number)
Wrapped in
towel

Naked
on Skin

Total

Not
skin-toskin

0

0

0

Yes,
skin-toskin

54

8

62

Total

54

8

62

delivery. However, 11% of women reported that this
practice took place, reflecting a substantial degree of false reporting (Box 8). A two-item indicator which
included women who positively answered “Did someone place the baby on your chest, against your skin
immediately after delivery” and subsequently reported the baby was lying naked against the skin to the
item “Was your baby wrapped in a towel while lying against your chest or lying naked against your skin,”
reduced false positive reporting. Women’s reported prevalence to the two-item skin-to-skin indicator
(1%) better approximated the observer report (<1%).
Instead of being placed naked skin to skin with the mother and then draped with a cloth, the standard
practice at the Mexico facility was for babies who were breathing at birth to be first wrapped with a
towel or cloth (99%). Babies were then brought near the mother for her to kiss on the cheek. This
contact with the baby may have confused women when asked about skin-to-skin contact. In addition,
because the practice of wrapping the newborn after birth was near universal, it was not possible to
assess the accuracy of women’s reporting on this indicator. However, cross-tabulation results show that
almost all of the women whose baby was not placed naked against their skin and was instead wrapped
in a towel accurately reported these circumstances (99%). These results should be interpreted with
caution since full validity analysis was not possible, and all babies not placed directly on the mother’s
skin were covered with a towel (in matched data).
Because the practice of bathing the baby within the first hour after birth rarely occurred, we were unable
to fully assess this practice (3% observed prevalence; <1% self-report prevalence). However, descriptive
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cross-tabulation results indicate high specificity for this indicator, that is, of the 429 newborns not
bathed within the first hour, 426 women correctly reported their newborn was not bathed (99%
specificity).
Composite indicator of essential newborn care
A composite indicator of 3 essential elements of newborn care (newborn was immediately dried, placed
skin-to-skin on mother’s chest, and breastfed in first hour) was constructed in analysis. This indicator
had a 10% self-reported prevalence by women and 0% observed prevalence. The zero observed
prevalence of the composite measure is due to the fact that only one newborn was observed to be
placed naked against the mother’s skin immediately following delivery. Using the two-item skin-to-skin
item in this composite indicator greatly reduced the reporting of false positives (<1% self-reported
prevalence).

IMMEDIATE POSTPARTUM NEWBORN CARE: SUMMARY
We were able to assess 3 indicators of immediate newborn practices: whether the baby was placed with
the mother immediately following birth, whether breastfeeding was initiated within the first hour of birth,
and whether something other than breastmilk was given to the baby to eat or drink within the first hour
of birth. No indicators met both study validity criteria. Question wording and order may have significant
implications for the validity of indicators of newborn thermal care.

Maternal Outcomes
Complications
Women were asked whether they experienced any of the following symptoms either during or
immediately following delivery: (1) high blood pressure, seizures, blurred vision, severe headaches, (2)
swelling in hands or face, (3) baby was in distress/ too large, (4) long labor (more than 12 hours), (5)
excessive bleeding, (6) infection (fever), (7) another type of complication (specify), or (8) no
complications. Over one-third (38%) of women reported experiencing some type of complication,
exceeding the observed prevalence (14%) by nearly 3 times. Women’s report of experiencing any type of
complication did not meet study validity criteria (Annex B). Self-reports of experiencing any complication
had a sensitivity of 61%, indicating that nearly 40% of women who had in fact experienced a
complication did not report it. The indicator also had moderately low specificity (65%), reflecting a high
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rate of false positive reports by women. Specifically, over one-third of women (35%) who had not
experienced a complication falsely reported experiencing one.
Box 9A. Descriptive frequencies: Complications.
Did you experience any of the following complications during
or after your delivery? (List all)
Number

Record whether mother had any of the following
complications. (Select all)

Percent

High blood pressure, seizure, blurred
vision, severe headache, swelling in
hands/face

150

25.05

Number

Percent

Pre-eclampsia/ eclampsia

14

2.32

Excessive bleeding

25

4.17

Hemorrhage

50

8.31

Baby was in distress/ too large

44

7.35

Obstructed labor

5

0.83

Long labor (more than 12 hrs)

51

8.51

Prolonged labor

13

2.13

Infection (fever)

33

5.51

Sepsis

0

0

Other

45

7.51

Other

6

0.99

No complications

371

61.94

No complications

520

86.24

0

0

Don’t Know

1

1.2

Don’t Know

Women most commonly reported experiencing eclampsia (i.e., high blood pressure, seizures, blurred
vision, severe headache and swelling in the hands or face) (25% self-reported prevalence), followed by
long labor (more than 12 hours) (9%), the baby was in distress or too large (7%) (indicative of fetal
distress or obstructed labor), infection (fever) (6%), and excessive bleeding (4%) (indicative of
hemorrhage) (Box 9A). An additional 8% of women reported some other type of complication, including
indications of gestational diabetes (high sugar), preterm or overdue newborn, nausea or vomiting, or not
becoming dilated enough to progress into labor.
There was sufficient variation to assess the
accuracy of women’s report of two
complications: pre-eclampsia/ eclampsia and

Box 9B. Cross-tabulation: Complication of hemorrhage.
Did you experience the following complication during or after your
delivery? Excessive bleeding.

hemorrhage (APH + PPH). The second

Observer Report (Number)

indicator met both study validity criteria (AUC:
however, that while this indicator had high
specificity (95%), its sensitivity was moderate

Self-Report
(Number)

0.7261 ± 0.04, IF: 1.04). It is noteworthy,

No

Yes

Total

No

519

24

543

Yes

26

24

50

Total

545

48

593

at 50%. These results suggest that while the
hemorrhage indicator would have a very low false positive rate, it would also miss half of women who in
fact experienced hemorrhage (Box 9B). However, the indicator did meet IF criteria, indicating that while
it may not be suitable for the individual classification of women, it would generate an acceptable
approximation of the population-based prevalence of the complication.
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The indicator of eclampsia did not meet study validity criteria and was in general overreported by
women. Specifically, if assessed by a population-based survey, the indicator would exceed the observed
prevalence of pre-eclampsia/eclampsia by over 9 times (IF: 9.1).

Post-delivery health checks
All women (100%) reported that the provider performed at least one of the following health checks in
the first physical examination after delivery: (1) check for bleeding, (2) perineal exam, (3) check for
involution (to see whether the womb was becoming firm), (4) took blood pressure, or (5) took
temperature (Box 9C). Observers indicated that 99% of women experienced at least one of these
checks. While there was insufficient variation in results to conduct validity analysis of this indicator, we
were able to assess the accuracy of women’s report of receiving a specific post-delivery check,
including: 1) bleeding, 2) examine the perineum, 3) temperature, 4) blood pressure, and 5) involution.
No indicators of specific post-delivery health
checks on the mother met both study validity
criteria (Annex B). While each indicator had
fairly high sensitivity (>90%) apart from a
slightly lower sensitivity for the provider check
on involution, each indicator was also
characterized by low specificity (i.e., high rates
of false positive reporting).
These findings reflect a tendency for most
women to report that the specific health checks

Box 9C. Descriptive frequencies: Post-delivery health checks.
In the first physical examination after delivery did the provider look, ask about,
or examine for: bleeding, perineal exam, involution, take blood pressure, or
take temperature?
Woman, %

Observer, %

Yes to any of following checks in first
physical examination post-delivery

100.00

99.30

Check for bleeding

87.46

80.51

Did a perineal exam

90.10

75.09

Checked to see whether womb was
becoming firm (involution)

83.45

81.65

Took blood pressure

93.38

95.59

Took temperature

93.34

66.89

took place, while observers did not report that the examinations occurred in all instances. Indicators of
whether the provider took the woman’s blood pressure in the first physical examination following
delivery and whether the provider took the woman’s temperature had notably low specificity levels
(<10%), indicating that the vast majority of women who did not receive this care reported that they had.
The low prevalence of instances when post-delivery health checks did not take place also indicates that
without near-perfect negative classification by women, these indicators are likely to be overestimated.
Another potential explanation for the discrepancy between observers’ and women’s report of postnatal
maternal health checks may be due to differences in timing. For example, data collectors anecdotally
noted that the first physical exam after birth would sometimes be delayed up to 2-3 hours following
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delivery, after study observation had concluded, or could have been conducted outside of the delivery
ward, in which case they would not have been seen by observers.
All indicators of immediate postnatal health checks on the mother (apart from whether the provider took
the woman’s temperature in the first physical examination following delivery) met the IF criteria,
suggesting that coverage of these indicators would approximate the population-based prevalence.
Other maternal outcomes
Other maternal outcomes assessed included whether the mother received an episiotomy, was given any
blood products during her stay in the facility, and whether she asked for or received pain medication at
any time. Each of these 4 indicators was assessed by robust analysis. Indicators of episiotomy and
blood products given met both study validity criteria.
Women reported receiving episiotomy with generally high accuracy (sensitivity: 98%, specificity: 63%,
AUC: 0.8041± 0.03, IF: 1.15), and this indicator met both validation criteria. Although receiving blood
products during the stay in the facility also met study validity criteria (AUC: 0.6706± 0.04, IF: 1.00), this
indicator was marked by low sensitivity (36%), indicating that approximately 65% of women who had
received blood products at some time during their stay did not report it. A woman requiring a blood
transfusion is likely to be in critical health, possibly asleep or unconscious, which might cause women
who received the intervention not to recall it.
Neither asking for nor receiving pain relief medication during the facility stay met both study validity
criteria. In particular, asking for pain relief medication was underreported by women (sensitivity: 33%,
specificity: 79%), while receiving pain medication tended to be overreported by women (sensitivity: 90%,
specificity: 20%), with a higher false positive rate. Whether the woman received pain relief medication
meet only the IF criteria.

MATERNAL OUTCOMES: SUMMARY
Women’s report of whether any complication occurred did not meet both study criteria and would be
overestimated nearly 3 times if assessed through a population-based survey. Indicators for two specific
complications had sufficient variation for robust analysis: whether hemorrhage or eclampsia was
experienced. The indicator of hemorrhage (whether excessive bleeding was experienced) met both
study validity criteria, but was marked by low sensitivity, suggesting nearly half of hemorrhage cases
would not be reported by women. However, the IF factor of approximately 1 indicates the indicator
would produce an acceptable population-based estimate of hemorrhage. The indicator of eclampsia did
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not meet the IF criteria and would likely be overestimated in a population-based survey. No indicator of
postpartum health checks met both validity criteria. In general, women tended to report that health
checks took place in all circumstances (regardless of whether they were observed to occur). The low
prevalence of instances when health checks did not take place increases the potential for overreporting
by women.
Other maternal outcomes examined included receiving episiotomy, receiving blood products at some
time during their facility stay, and asking for and receiving pain medication. Two indicators, receiving
episiotomy and blood products, met both validity criteria. Receiving blood products, however, was
notably underreported by women, and approximately 65% of women who had received blood products
did not report receiving the intervention.

Newborn Outcomes
Newborn birthweight
Observers’ and women’s self-reports of newborn gram weight were very highly correlated (r= 0.97). The
high degree of correlation may partially reflect the standard facility practice of providing each mother
with a bracelet that listed her newborn’s birthweight, which may have increased the salience of this
indicator. To account for this, validity analysis was restricted to women who reported their newborn’s
weight themselves, rather than taking the weight from a card (which occurred in 3 cases). We classified
newborn birthweight into 3 categories: low birthweight (<2,500 grams), normal birthweight (2,5004,499 grams), and high birthweight >4,500 grams). Most newborns were normal weight (88%), 12%
were low birthweight, and none were high birthweight.
Women’s self-report of low and normal newborn birthweight was near perfect. Specifically, all women
who delivered a low birthweight newborn accurately reported their newborn’s weight to be less than
2,500 grams (100% sensitivity); the indicator also had 99% specificity. Similarly, normal newborn
birthweight was reported with 99% sensitivity and 100% specificity. Given the lack of variation in the
data, we were unable to analyze these indicators fully. However, women’s near-perfect reporting
accuracy indicates that this information was highly memorable. While the high accuracy may be in part
due to the practice of providing women with a bracelet that listed their newborn’s weight, study
interviewers also agreed that information related to the baby’s weight seemed to be important to
women and was easily recalled.
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Stillbirth delivery
Given the small number of stillbirth deliveries (n=3 observed, matched data n=2 due to missing data in
client exit interview), we were unable to analyze the
validity of an indicator of stillbirth deliveries. While

Box 10. Cross-tabulation: Stillbirth delivery.
Observer Report (Number)

results should be interpreted with caution,

Alive

Stillbirth

Total

Alive

589

0

589

Stillbirth

0

2

2

Total

589

2

591

both stillbirth deliveries were correctly classified by
women.

Self-Report
(Number)

descriptive cross-tabulations (Box 10) indicate that

NEWBORN OUTCOMES: SUMMARY
Newborn birthweight was nearly perfectly reported by women, and likely reflected the fact that all
women were given a bracelet with the newborn’s birthweight listed. Very few newborns were stillborn,
but the 2 stillborn cases that occurred were accurately reported.
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Discussion
Overview:
48 out of 108 possible indicators had sufficient variation in numbers for validity analysis. Of these, 5
indicators met both acceptability criteria (AUC>0.6 and 0.75<IF<1.25) (Table 4). 28 of these indicators
met only one of the acceptability criteria. Few indicators met both study validity criteria, in part because
many quality of care interventions were either routinely practiced or rarely occurred (see Annex A, Table
2). As a result, there was often insufficient variation in women’s and observers’ reports for robust
validity analysis.
Validated Indicators that Met Study Validity Criteria
Study findings suggest women’s report of indicators
that ‘became significant for them’ were most likely to
be validly reported. Salient events included aspects
of care that had caused pain, such as receiving an
episiotomy, or were cause for concern, such as
experiencing hemorrhage or receiving a blood
transfusion. It is noteworthy, however, that although

TABLE 4. Indicators that met both validation
criteria.
Provider takes a urine sample at or near facility
admission
Injection or IV medication received at some time
during labor, before the birth of the baby
Episiotomy was performed
Complication of hemorrhage was experienced
Blood products were given

indicators on urine sample screening, experiencing hemorrhage, and receiving blood products met
study validity criteria, each of these indicators had low sensitivity (50% for urine sample and
hemorrhage; 36% for blood products). These findings indicate that of women who experienced these
events, half or more did not report it. Because postpartum hemorrhage is a leading cause of maternal
death, and blood transfusion and a urine screen for pre-eclampsia/eclampsia are potentially lifesaving
interventions, the low sensitivity of these indicators would not capture critical information regarding the
women who experienced these events. If the goal of using these indicators is not to obtain an accurate
record of true positive and true negative cases, but rather to approximate the prevalence of the
indicators in the population, the IF of nearly 1 suggests that the indicators may be suitable to estimate
coverage at an aggregate level.
Receiving an injection or IV medication at some time during labor, before the birth of the baby (proxy for
uterotonic for labor induction or augmentation), also met both validity criteria. The high sensitivity (70%)
of this indicator may reflect the observation that upon admission to the labor /delivery ward it was
universal practice for women to have an IV line set, which also likely decreased the use of alternative
drug administration routes. Taken together, these results suggest women may be able to report whether
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an injection or IV medication was received, but not on the indication for the intervention (whether the
medication was received for induction or augmentation of labor).

Indicators on Skilled Birth Attendance
A key objective of the study was to assess the validity of women’s reports of ‘skilled attendance at
birth’, i.e., what category of provider assisted with labor and delivery. Skilled birth attendance (i.e.,
doctor/ob-gyn, medical resident, or nurse) was common, with greater than 90% observed prevalence
regardless of delivery phase or provider role (main provider or additional provider present). Crosstabulation results (additional provider indicator) reflect high sensitivity and low specificity of women’s
self-reports on skilled birth attendance. However, given there were few instances when a skilled
provider was not present, these results demonstrate that unless women had near perfect specificity in
reporting, this indicator is likely to be overestimated.
Of specific relevance to this context was to test women’s accuracy in identifying when the main provider
belonged to a skilled category. The skilled provider most commonly observed was a medical resident
(>92% across delivery phases). Of note is that in Mexico, there is little distinction between the skill level
of a medical resident and other doctor categories (general practitioners, ob-gyn specialists) since they
would all be classified as skilled providers. We therefore assessed the validity of a composite doctor/obgyn/medical resident indicator. This composite indicator did not meet both validity criteria, irrespective
of delivery phase or provider role (main provider or additional provider present). Similar to ‘skilled birth
attendance’, the doctor/ob-gyn/medical resident indicator was marked by high sensitivity and low
specificity. As with the ‘skilled provider’ indicator, our results are limited by the lack of variation in
provider type, since the tendency to overreport low-prevalence scenarios was common when specificity
levels were not high.
The discrepancy in reporting on ‘skilled birth attendance’ and doctor/medical resident indicators may
also reflect differences in how women and observers identified the provider with the ‘main’ role.
Observers report identifying the primary provider as the staff member who spent the most time or
conducted the majority of actions during labor or delivery. It is possible that women instead
conceptualized the ‘main’ provider as the birth attendant who had the highest rank and was deemed to
be ‘in charge’ of care. The high number of attendants at each birth (mean: 4 ± 2) and the setting of a
teaching hospital setting may also have contributed to women’s difficulty in identifying the ‘main’
provider. Future qualitative analysis is recommended to explore how women understand key terms in
birth attendant indicators and women’s understanding of the existence and differences between the
doctor cadres.
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While the low prevalence of instances when a skilled doctor was not present limited our ability to
analyze whether women could distinguish among finer categories of providers, it is important to note
that 8 birth attendant indicators met the IF criteria alone. This included whether the main provider who
caught the newborn during delivery was a doctor/ob-gyn or medical resident. Birth attendant indicators
that met the IF criteria alone may be useful for assessing the population-based coverage of these
provider types. Given that broad categorizations of provider levels (i.e., whether the provider is skilled or
some type of doctor) are likely to be more programmatically meaningful than the ability of women to
delineate between specific provider types, the composite doctor indicator may be of particular use at
the population level.
Validated Indicators that Met At Least One Study Validity Criteria
In addition to skilled birth attendance, other core indicators have high potential for practical use. We
define ‘core’ indicators as those included in DHS and MICS surveys, or that reflect essential aspects of
obstetric and immediate newborn care. Core assessed indicators that met at least one validity criteria
were: HIV status checked, receiving a uterotonic up to 3 minutes following the birth and whether 3
essential components of AMTSL were received. Each of these indicators met the IF validation criteria
alone, suggesting they may produce an acceptable estimate of indicator prevalence at the population
level. Because these indicators did not meet the AUC criteria, they are not recommended for classifying
which individual women received a specific intervention. However, at the aggregate level, the tendency
for underreporting of true cases and overreporting of false cases cancel out to produce an acceptable
population-based estimate.

Indicators Reported with Difficulty
Other indicators were reported with difficulty and had notably high ‘Don’t Know’ responses by women.
These include measures of specific medications or injections received, HIV testing, provider hygiene
(hand sanitization or sterile glove use), aspects of immediate postpartum care (whether baby was
immediately dried after birth, when the baby was first bathed, whether the baby was given anything else
to eat or drink in the first hour after birth), and provider health checks for involution (whether the womb
was becoming firm) in the first health exam post-delivery (see Annex A, Table 3).
The high ‘Don’t Know’ responses on these indicators reflect study interviewer notes for indicators where
they had to provide additional clarification to explain questions or terms to women. For example, HIV
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was commonly confused with HPV, and interviewers frequently explained the difference between the
two distinct sexually transmitted diseases. Interviewers also had to provide lengthy explanations about
differences between receiving an epidural and other types of injections or IV medications. Interviewers
commonly noted using body language to demonstrate the place where an epidural relative to other
injections was administered. Other indicators where interviewers felt they had to provide additional
clarification related to questions using the term ‘immediate’. While allowing for an initial spontaneous
response from the woman, the interviewer would then specify that the question referred to an
‘immediate action’ and sometimes asked the woman to estimate the number of minutes that had
passed to enable her to respond more accurately to the question.
Women also had difficulty reporting some aspects of interventions related receiving uterotonics. This
result is supported by women‘s high ‘Don’t Know’ responses on indicators of uterotonic administration
for PPH—whether oxytocin was received following delivery or whether anyone gave medication
intravenously through a tube in the first few minutes after delivery (37% and 7%, respectively). The fact
that some women accurately reported receiving medication by IV line following delivery, but did not
report receiving oxytocin, despite being observed to receive oxytocin via IV line in this time period (Box
5D), could suggest that women recall having an IV line set because it was standard practice, but did not
have specific knowledge of uterotonics received. Taken together, these results suggest that women can
report some aspects of care routinely received, but may have difficulty with specific details (timing,
name, route of administration) of medications received. This is likely because intervention procedures,
in general, and specifically those regarding the use of medications were rarely explained to women, as
noted by observers. Indicators regarding receiving uterotonics should be used with consideration of
whether the purpose is to classify individual women who received the intervention, or to obtain an
acceptable coverage estimate of the intervention at the population level. IF results suggest that one
indicator— whether a uterotonic was received up to 3 minutes following delivery—may produce valid
results only at the aggregate level.
In addition to data collector notes, quantitative findings also highlight the importance of indicator
wording on women’s reporting. For example, a two-item indicator about whether the newborn was
placed skin-to-skin on the mother’s chest immediately after delivery greatly reduced women’s
overestimation of the practice compared to a one-item indicator. Quantitative findings and observer
notes also suggest that women have difficulty reporting details related to the specific timing, routes,
and names of medications received. These results suggest that women’s conceptualization of key terms
used in survey items (e.g., understanding of directly ‘on skin’ as opposed to wrapped in a towel and
placed on the skin, and terms such as ‘immediate’ or ‘within a few minutes’) should be further explored
to better refine indicators.
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Indicators to be Further Researched
Because institutional delivery is a widely used proxy of whether women have access to comprehensive
services such as emergency obstetric care and lifesaving commodities (e.g., uterotonics, magnesium
sulfate, antibiotics), it is of interest whether women can accurately report on the type of facility where
they delivered. The present study was not designed to assess whether women can accurately report on
this indicator. However, cross-tabulation results show that a high proportion of women (85%) who
responded to this indicator correctly classified the type of facility as a public/ government hospital.
Additionally, of women not able to classify the study facility as private or public, the majority (83%)
correctly named the facility and 4% specified details including whether the facility was a hospital and
part of the public or governmental sector. These results suggest that both aspects of question
methodology, also used in DHS and MICS surveys, are important. These findings should be explored
further in a study that includes multiple facility types (private and public sector).
An additional indicator, which we were unable to assess because of near-perfect correlation between
observers’ and women’s responses, but which suggests the potential for valid reporting, was newborn
birthweight. Specifically, women reported normal (2,500-4,499 grams) and low (<2,500 grams)
newborn birthweight with near 100% accuracy. While the hospital practice of giving women bracelets
listing the newborn birthweight, may have increased the salience of this indicator, analysis was
restricted to women who recalled the weight from memory. Study interviewers also anecdotally
corroborated the seeming importance of newborn birthweight, as women readily recalled the number.
Occasionally women were able to recall only the amount in kilos and confirmed the grams after looking
at their bracelet. Interviewers also noted that although not questioned on it, women spontaneously
reported on the time of birth as another memorable event.
Another general trend observed was that some universal practices, particularly related to the client’s
initial assessment or the mother’s post-partum health checks, were reported with high sensitivity by
women. Although the high prevalence of these indicators limited robust analysis, it is noteworthy that in
the few cases where women did not receive these preventative interventions, a high proportion of
women falsely reported receiving them, suggesting low specificity. Because there were too few
instances of women not receiving this type of care to robustly assess these indicators, this trend should
be further explored. These findings may suggest that women in the Mexico setting may be positively
biased towards reporting on aspects of preventative care received in the initial assessment and on
health checks for the mother in the post-partum maternal period. It may also reflect the fact that, with
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regard to low- prevalence scenarios, lack of high specificity in women’s self-report may led to
overestimation of the indicator.
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Annexes
Annex A.
TABLE 1. Full List of Indicators Assessed and Measured Coverage,a,b Mexico.

Indicator

Self-Report Prevalence
(Matched data)

True Prevalence
(Matched data)

At least 5
counts/cell?

Initial Client Assessment
Type of facility where gave birth- public hospital

85.20

100.00

N

HIV status checked

54.13

69.77

Y

Offered HIV test

14.31

1.79

N

Received HIV test

16.32

1.17

N

Provider washes hands with soap and water or uses
antiseptic before any initial examination

95.85

1.97

N

Takes blood pressure

98.80

97.77

N

Takes urine sample

24.30

25.17

Y

Checks fetal heart rate with fetoscope/ ultrasound

97.78

97.78

N

Wears high-level disinfected or sterile gloves for vaginal
examination

100.00

99.65

N

Provider Respectful Care
Encourages/assists woman to ambulate during labor

8.28

22.24

Y

Woman allowed to drink liquids/eat

2.88

0.51

N

Woman allowed to have a support person present
during labor and delivery

0.35

0.00

N

Encourages/assists woman to assume different
positions in labor

3.90

67.63

N

A support person is present at some point during labor

0.17

0.85

N

A support person is present at birth

0.17

1.02

N

12.88

11.63

Y

(Of women whose labor was induced) Uterotonic route
for induction of labor by IV line d

27.69

100.00

N

Augments labor with uterotonic (by IV line, IM
injection, or tablet) d

41.95

75.21

Y

(Of women whose labor was augmented)
Augmentation of labor by IV line d

57.25

100.00

N

Receives injection during labor (to induce or augment
labor) d

49.79

76.05

Y

Injection or IV medication received at some time during
labor, before birth of baby (general)

63.57

76.01

Y

Membranes ruptured (to induce or augment labor) d

26.97

57.02

Y

First Stage of Labor
Induces by uterotonic (IV line, IM injection, or tablet)

1

d

Indicator

Self-Report Prevalence
(Matched data)

True Prevalence
(Matched data)

At least 5
counts/cell?

Skilled Birth Attendance- Main Provider
Skilled main provider labor c, d

95.69

96.72

N

Main provider labor- doctor or medical resident d

81.90

96.21

Main provider labor- doctor (any)

76.72

1.72

N
N

Main provider labor- medical resident

5.17

94.48

N

Main provider labor- medical intern

3.62

3.28

N

Main provider labor- nurse

13.79

0.52

N

Main provider labor- nursing student /intern

0.69

0.00

N

Skilled main provider delivery c, d

97.77

92.81

N

Main provider delivery- doctor or medical resident†

95.66

92.36

N

Main provider delivery- doctor (any)

92.81

2.40

N

Main provider delivery- medical resident

2.91

90.07

N

Main provider delivery- medical student/ intern

2.23

7.19

N

Main provider delivery- nurse

2.05

0.34

N

Main provider delivery- nursing student /intern

0.00

0.00

N

96.98

92.18

89.70

91.12

N
Y

Main provider caught baby- doctor (any)

85.79

10.12

N

Main provider caught baby- medical resident

3.91

80.99

N

Main provider caught baby- medical student/ intern

2.31

7.82

N

Main provider caught baby- nurse

7.28

1.07

N

Main provider caught baby- nursing student /intern

0.17

0.00

N

Skilled main provider caught baby c, d
Main provider caught baby- doctor or medical resident

d

Skilled Birth Attendant- Other Providers Present
Skilled other provider labor

92.05

96.95

N

Other provider labor- doctor or medical resident

70.39

84.60

Y

Other provider labor- doctor (any)

65.65

20.14

Y

Other provider labor- medical resident

11.76

77.65

Y

Other provider labor- medical student/intern

23.01

65.31

Y

Other provider labor- nurse

62.61

80.88

Y

Other provider labor- nursing student/intern

7.45

17.77

Y

Skilled other provider delivery

97.14

97.98

N

Other provider delivery- doctor or medical resident

82.32

88.22

Y

Other provider delivery- doctor (any)

79.46

24.58

Y

Other provider delivery- medical resident

13.79

81.56

Y

Other provider delivery- medical student/intern

26.26

39.06

Y

Other provider delivery- nurse

81.14

81.99

Y

Other provider delivery- nursing student/intern

6.90

9.26

Y

Other provider delivery- pediatrician

39.40

6.84

Y

Other provider delivery- anesthesiologist

9.76

4.55

Y

2

c, d

c, d

Indicator

Self-Report Prevalence
(Matched data)

True Prevalence
(Matched data)

At least 5
counts/cell?

Number of Providers
Four or more providers assisted with birth d

94.44

66.16

More than six providers assisted with birth

37.54

13.64

Y
Y

More than seven providers assisted with the birth

23.23

5.72

Y

Second & Third Stage of Labor
Episiotomy performed

78.10

67.76

Y

Position of mother at birth- on back

93.30

99.66

N

Did health provider wear gloves during delivery of baby

99.82

99.29

N

Uterotonic administered within few minutes of delivery (IV
line, IM injection, or tablets)

60.88

99.33

Uterotonic received 1-3 minutes after delivery

60.69

63.97

N

Uterotonic received after delivery of placenta

94.10

19.97

Y

Method of uterotonic administration- IV line

62.20

100.00

N

Oxytocin given following delivery

50.00

99.16

N

Applies controlled cord traction

93.83

96.91

N

Performs uterine massage after birth

82.37

83.07

Y

Palpates uterus 15 minutes after delivery of placenta

79.66

82.41

Y

3 AMTSL elements: prophylactic uterotonic, controlled cord
traction, uterine massage post-placenta d

75.77

81.18

Y

N

Immediate Newborn Care (babies breathing at birth)
Baby immediately dried with towel/cloth

99.27

93.58

N

Baby given to mother immediately after birth

59.83

10.34

Y

Baby placed immediately skin-to-skin on mother's abdomen

11.36

0.17

N

Baby immediately skin-to-skin on mother (2 item) d,e

1.05

0.17

N

Babies not on skin wrapped with towel

99.12

98.77

N

Breastfeeding within 1st hour of birth

64.81

34.74

Y

Something other than breastmilk given to baby within 1 st
hour of delivery

57.76

21.69

Y

Baby bathed within the first hour after birth d

0.68

2.72

N

Baby weighed

98.81

NA

N

12.05

11.21

N

0

0

N

3 elements of newborn care (newborn immediately dried +
placed naked on skin + breastfed within 1st hr) d

9.66

0.00

N

3 elements of newborn care (newborn immediately dried +
placed naked on skin (2 item) e + breastfed within 1st hr) d

0.74

0.00

N

Low birth-weight baby (<2,500 g) d
High birth-weight baby (>=4,500 g)

d

Immediate Postnatal Care
Provider did at least one post-delivery health check d

100.00

99.30

N

In first post-delivery exam, checks for bleeding

87.46

80.51

Y

In first post-delivery exam, examines perineum

90.10

75.09

Y

3

Indicator

Self-Report Prevalence
(Matched data)

True Prevalence
(Matched data)

At least 5
counts/cell?

In first post-delivery exam, takes temperature

93.34

66.89

Y

In first post-delivery exam, takes blood pressure

93.38

95.59

Y

In first post-delivery exam, checks for involution

83.45

81.65

Y

Maternal and Newborn Outcomes
Cesarean section (C/S) performed

9.68

9.98

N

Decision for C/S taken after labor started

84.62

94.87

N

C/S performed after labor started

84.62

94.87

N

Provider decided C/S would be done

97.30

100.00

N

Reason for C/S- prolonged/ obstructed labor

21.62

29.73

Y

Complications (any)

38.15

13.61

Y

Eclampsia

21.38

2.36

Y

Hemorrhage

8.43

8.09

Y

Prolonged labor (>12 hours)

7.39

2.18

N

Prolonged/obstructed labor

10.76

3.03

N

None

61.85

86.39

Y

Blood products given

2.41

2.41

Y

Woman asked for pain relief medication while at facility

26.26

44.70

Y

Woman received pain relief medication

87.44

79.35

Y

Stillborn delivery d

0.34

0.34

N

a Text

in blue notes indicators where there was not sufficient cell counts for robust analysis (n<5 per cell).
b Excludes ‘Don’t Know’ responses.
c Skilled provider is doctor (ob-gyn), nurse/midwife or medical resident
d Indicator constructed in analysis to dichotomize women’s responses to related question.
e Indicator constructed from two skin-to-skin items: (1) baby placed against mother’s chest after delivery and (2) baby was naked against the
mother’s chest.
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Annex A.
TABLE 2. Near Universal and Rare Indicators, Unmatched Data

Indicator

True Prevalence

Near Universal practices (>95%)
Provider takes woman’s blood pressure

99.8

Fetal heart rate checked with fetoscope/Doppler ultrasound

97.8

Provider wore high-level disinfected or sterile gloves for vaginal examination

99.7

(Of those with induced labor), route for induction of labor by IV line

100.0

(Of those with augmented labor), route for augmentation of labor by IV line

100.0

Skilled main provider during labor (doctor, medical resident, or nurse)

96.7

Skilled additional provider during labor (doctor, medical resident, or nurse)

97.0

Skilled additional provider at delivery (doctor, medical resident or nurse)

97.1

Main provider during labor- medical resident
Health provider wore gloves during delivery

99.3

Position of mother at birth – on back

99.7

Prophylactic uterotonic administered

99.3

Method of prophylactic uterotonic- IV line

100.0

Oxytocin given following delivery

96.2

Controlled cord traction

96.9

Newborn not placed skin-to-skin, wrapped in dry towel

98.8

Provider did at least one post-delivery health check

99.3

Of those who received cesarean section, provider made decision

100.0

Rare practices (<5%)

5

Offered HIV test

1.8

Woman received HIV test

1.2

Provider washes hands with soap and water or uses antiseptic before each examination

2.0

Takes urine sample

1.4

Woman is allowed to drink liquids or eat during labor

0.5

Woman is allowed to have support person present during labor and delivery

0.0

A support person is present at some point during labor

0.9

A support person is present at birth

1.0

Main provider labor – nurse

0.5

Main provider labor – nursing student/ intern

0.0

Newborns placed immediately skin-to-skin on mother’s abdomen

0.2

Newborns placed directly on mother’s skin are covered with dry towel on mother’s abdomen

0.0

Baby bathed within the first hour after birth

2.7

Annex A.
TABLE 3. Indicators with High ‘Don’t Know’ Responses, Unmatched data
Indicator

% “Don’t
Know”

Woman’s Self-Report (>5% DK)
Did anyone give you a medication called ‘oxytocin’ to make your womb contract or become firm?

37.3

Did anyone give you medication or an injection called ‘oxytocin’ before you delivered the placenta?

35.8

While you were at the health facility for the birth of your baby, did anyone test you for HIV?

23.2

Did you or anyone else give anything to the baby to eat or drink within the first hour after delivery?

21.0

Did the health provider(s) wash their hands with soap and water or use antiseptic before examining
you?

18.9

In the first few minutes after the delivery of your baby, did anyone give you medication intravenously
through a tube in your arm?

6.9

Was your baby dried off with a towel or cloth immediately after birth, within a few minutes of delivery?

6.4

About how long after birth was your baby bathed for the first time?

5.9

In your first physical examination/check after delivery, did a health provider check your belly to see
whether your womb was becoming firm?

5.7

Did the health providers wear rubber gloves to handle the placenta?

5.4

Observers’ Self-Report (>2% DK)

6

Was anything besides breast milk given to the baby to drink within the first hour after birth?

5.6

Was an HIV test done?

4.1

Provider performs artificial rupture of the membranes

4.1

Provider checks woman’s HIV status (checks chart or asks woman)

3.3

Provider washed his/her hands with soap and water or used antiseptic before each
examination of the woman

3.3

Provider ties or clamps cord when pulsations stop or by 2-3 minutes after birth (not
immediately after birth).

3.0

Did the woman ask for any pain relief medication during labor, delivery, or immediately
postpartum?

2.8

Provider takes urine sample to check for presence of proteins

2.6

Baby bathed within the first hour after birth.

2.5

What was the indication for the cesarean operation?

2.4

Provider encourages woman to have a support person present throughout labor and birth

2.1

Annex B.
TABLE 1. Validation Results for ALL Indicators With at Least 5 Counts per Cell, Matched Data *, Mexico.
Reported
Prev (%)

True Prev
(%)

Matched
data

Matched
data

Matched
data

HIV status checked

569

54.13

69.77

Takes urine sample

572

24.30

25.17

580

8.28

Induces labor with uterotonic

559

Augments labor with uterotonic
Receives injection for induction or augmentation of labor
Injection or IV medication received at some time during labor,
before birth of baby (general)
Membranes ruptured (labor induction or augmentation)

N

Specificity of
Self-Report

Population
Survey
Estimate

54.91

47.67

50.00

84.35

22.24

7.75

12.88

11.63

472

41.95

476

Sensitivity of
Self- Report

IF
AUC

Recommend?

(>0.60)

(0.75
to
1.25)

(Y/N)
List Criteria

54.13

0.5129

0.78

IF

24.30

0.6717

0.97

Yes

91.57

8.28

0.4966

0.37

27.69

89.07

12.88

0.5838

1.11

IF

75.21

49.58

81.20

41.95

0.6539

0.56

AUC

49.79

76.05

59.12

79.82

49.79

0.6947

0.65

AUC

571

63.57

76.01

70.05

56.93

63.58

0.6349

0.84

Yes

356

26.97

57.02

38.42

88.24

26.96

0.6333

0.47

AUC

580

81.90

96.21

82.26

27.27

81.90

0.5477

0.85

IF

563

89.70

91.12

90.06

14.00

89.70

0.5203

0.98

IF

Other provider during labor was skilled a

591

92.05

96.95

92.15

11.11

92.05

0.5163

0.95

IF

Other provider during labor – doctor or medical resident

591

70.39

84.60

71.80

37.36

70.39

0.5458

0.83

IF

Other provider during labor – doctor (any)

591

65.65

20.14

72.27

36.02

65.65

0.5414

3.26

Other provider during labor – medical resident

595

11.76

77.65

12.34

90.23

11.77

0.5128

0.15

Other provider during labor – medical student /intern

591

23.01

65.31

25.65

81.95

23.01

0.5380

0.35

Other provider during labor – nurse

591

62.61

80.88

64.02

43.36

62.61

0.5369

0.77

Other provider during labor – nursing student/ intern

591

7.45

17.77

8.57

92.80

7.44

0.5068

0.42

Other providers during delivery - doctor or medical resident

594

82.32

88.22

82.82

21.43

82.32

0.5213

0.93

Indicator
Initial Client Assessment

Provider Respectful Care
Encourages/assists woman to ambulate during labor
First Stage of Labor

Skilled Birth Attendance
Main provider
Main provider labor- doctor or medical resident
Main provider delivery (who caught baby)– doctor or
medical resident
Other providers present
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IF
IF

N
Indicator

Matched
data

Reported
Prev (%)

True Prev
(%)

Matched
data
79.46

Matched
data
24.58

IF

Specificity of
Self-Report

Population
Survey
Estimate

(>0.60)

81.51

21.21

79.46

Sensitivity of
Self- Report

AUC

Recommend?

(Y/N)
List Criteria

0.5136

(0.75
to
1.25)
3.23

AUC

Other providers during delivery - doctor (any)

594

Other providers during delivery - anesthesiologist

594

9.76

4.55

33.33

91.36

9.76

0.6235

2.15

Other providers during delivery - pediatrician

599

39.40

6.84

41.46

60.75

39.40

0.5111

5.76

Other providers during delivery – medical resident

602

13.79

81.56

13.65

85.59

13.79

0.4962

0.17

Other providers during delivery – medical student/ intern

594

26.26

39.06

31.03

76.80

26.26

0.5392

0.67

Other providers during delivery – nurse

594

81.14

81.99

82.96

27.10

81.15

0.5503

0.99

IF

Other providers during delivery – nursing student/ intern

594

6.90

9.26

5.45

92.95

6.90

0.492

0.75

IF

Episiotomy performed

580

78.10

67.76

97.71

63.10

78.10

0.8041

1.15

Yes

Uerotonic received 1-3 minutes after delivery

580

60.69

63.97

61.46

40.67

60.69

0.5106

0.95

IF

Uterotonic received following delivery of placenta

576

94.10

19.97

95.65

6.29

94.10

0.5097

4.71

Palpates uterus 15 minutes after delivery of placenta

580

79.66

82.41

79.50

19.61

79.66

0.4955

0.97

IF

3 AMTSL elements: prophylactic uterotonic + controlled cord
traction + uterine massage post-delivery of placenta

549

75.77

81.18

75.72

24.00

75.7

0.4986

0.93

IF

4+ providers assisted with the birth

573

82.37

83.07

82.14

16.49

82.37

0.4932

0.99

IF

7+ providers assisted with the birth

594

37.54

13.64

59.26

65.89

37.54

0.6257

2.75

AUC

8+ providers assisted with the birth

594

23.23

5.72

50.00

78.39

23.24

0.6420

4.06

AUC

580

59.83

10.34

63.33

40.58

59.82

0.5196

5.78

Breastfeeding within
of birth
Something other than breastmilk given to baby within 1st hour
of birth
Immediate Postnatal Care

449

64.81

34.74

81.41

44.03

64.81

0.6272

1.87

438

57.76

21.69

71.58

46.06

57.77

0.5882

2.66

First post-delivery exam, provider ask/checks for bleeding

590

87.46

80.51

87.37

12.17

87.46

0.4977

1.09

IF

First post-delivery exam, provider examines perineum

586

90.10

75.09

90.23

10.27

90.11

0.5025

1.20

IF

First post-delivery exam, provider takes temperature

586

93.34

66.89

94.39

8.76

93.35

0.5158

1.40

First post-delivery exam, provider takes blood pressure

589

93.38

95.59

93.25

3.85

93.38

0.4855

0.98

IF

First post-delivery exam, provider checks for involution

556

83.45

81.65

84.58

21.57

83.45

0.5308

1.02

IF

Second and Third Stage Labor

Immediate Newborn Care
Baby given to mother immediately after birth
1st hour

8

AUC

Reported
Prev (%)

True Prev
(%)

Matched
data

Matched
data

Matched
data

595

38.15

13.61

Eclampsia

594

21.38

Hemorrhage

593

None

N
Indicator

Specificity of
Self-Report

Population
Survey
Estimate

60.49

65.37

2.36

57.14

8.43

8.09

Sensitivity of
Self- Report

IF
AUC

Recommend?

(>0.60)

(0.75
to
1.25)

(Y/N)
List Criteria

38.15

0.6293

2.80

AUC

79.48

21.38

0.6831

9.07

AUC

50.00

95.23

8.43

0.7261

1.04

Yes

Maternal Outcomes
Complication (yes to any)

595

61.85

86.39

65.56

61.73

61.84

0.6365

0.72

AUC

Blood products given

582

2.41

2.41

35.71

98.42

2.40

0.6706

1.00

Yes

Woman asked for pain relief medication at some time

575

26.26

44.70

32.68

78.93

26.26

0.5581

0.59

Woman received pain relief medication

581

87.44

79.35

89.37

20.00

87.43

0.5469

1.10

* Excluding
a

‘Don’t Know’ responses.
Skilled provider includes doctor (ob-gyn), medical resident or nurse/midwife.
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